EXHIBIT 10.1

      SECURITIES PURCHASE AGREEMENT , dated as of June 14, 2005 (the “Agreement”), between COMPREHENSIVE CARE CORPORATION , a Delaware corporation (the “Company”) and WOODCLIFF HEALTHCARE INVESTMENT PARTNERS LLC , a Delaware limited liability company (the “Buyer”).

     Whereas, at the Closing and on the terms and conditions set forth in this Agreement, the Company wishes to issue and sell to the Buyer, and the Buyer wishes to purchase from the Company, an aggregate of 14,400 shares of the authorized but unissued Series A Convertible Preferred Stock, par value $50.00 per share, of the Company (the “Series A Preferred Shares”), at an aggregate purchase price of $3,600,000 ($250.00 per share);

     Whereas, on the terms and conditions set forth in this Agreement, the Buyer has agreed to purchase Put Option Shares at the Put Option Closings in FY 2006 and FY 2007.

     NOW, THEREFORE, in consideration of the premises and the mutual covenants contained in this Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound, the parties agree as follows:

ARTICLE 1

DEFINITIONS

     Unless otherwise indicated in this Agreement, all terms defined in the Certificate of Designation shall be deemed to have the same definitions in this Article 1.

     “ Affiliate ” of any Person means any other Person, directly or indirectly, controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, “control” when used with respect to any Person means the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing.

     “ Balance Sheet ” means the unaudited consolidated balance sheet of the Company as at February 28, 2005.

     “ Balance Sheet Date ” means February 28, 2005.

     “ Basic Documents ” means this Agreement, the Preferred Shares, the Certificate of Designation, the Registration Rights Agreement, each of the Employment Agreement Amendments and each of the Employee Waivers.

     “ Benefit Plans ” means as defined in Section 3.24 of this Agreement.

     “ Business Day ” means a day other than a Saturday, Sunday or other day on which commercial banks in New York City are authorized-or required by law to close.

     “ capital stock ” of any Person means any and all shares, interests, participations or other equivalents (however designated) of such Person’s capital stock (or equivalent ownership interests in a Person not a corporation) whether now outstanding or issued after the date of this Agreement, including, without limitation, all Common Stock and Preferred Stock and any rights, warrants or options to purchase such Person’s capital stock.

     “ Certificate of Designation ” means the Certificate of Designation to be filed by the Company with the Secretary of State of the State of Delaware on, and to be effective as of, the Closing Date, and amending the Certificate of Incorporation of the Company and authorizing the issuance of the Series A Preferred Shares, a form of which is attached hereto as Exhibit A.

     “ Change of Control ” means for the purposes of this Agreement only, any event or series of events by which (i) other than a result of a re-sale of the Securities by the Buyer, any Person or group obtains a majority (by voting or otherwise) of the securities of the Company ordinarily having the right to vote in the election of directors, (ii) other than as a result of a re-sale or conversion of the Securities by the Buyer, during any two-year period, Persons who at the beginning of any such two-year period constituted the Board of Directors of the Company (together with any new directors whose election by such Board or whose nomination for election by the stockholders of the Company was approved by a vote of the majority of the directors then still in office who were either directors at the beginning of such period or whose election, recommendation or nomination for election was previously so approved) cease for any reason to constitute a majority of the Board of Directors of the Company if, as a result, the stockholders of the Company as of the Closing Date no longer own more than 50% of the voting securities of the Company, (iii) any sale, lease, exchange or other transfer of all or substantially all of the assets of the Company in one or a series of transactions, (iv) the adoption of a plan leading to the liquidation or dissolution of the Company.

     “ Closing ” means the consummation of the issuance and sale by the Company to the Buyer of the Series A Preferred Shares in accordance with the terms and conditions of this Agreement.

     “ Closing Date ” means the date on which the Closing occurs.

     “ Code ” means the Internal Revenue Code of 1986 and the U.S. Treasury Department regulations promulgated thereunder, all as amended from time to time.

     “ Common Shares ” means the shares of Common Stock issuable to the Buyer upon conversion of the Series A Preferred Shares or exercise by the Company of the First Put Option, the Second Put Option or the Variable Price Put Option, or otherwise in accordance with the terms and conditions of this Agreement and the other Basic Documents.

     “ Common Stock ” means the common stock of the Company, par value $0.01 per share.

     “ Company ” has the meaning set forth in the preamble.

-2-

     “ Contingent Obligation ” as to any Person shall mean any obligation of such Person guaranteeing or intended to guarantee any Indebtedness, leases, dividends or other obligations (“primary obligations”) of any other Person (the “primary obligor”) in any manner, whether directly or indirectly, including, without limitation, any obligation of such Person, whether or not contingent, (a) to purchase any such primary obligation or any property constituting direct or indirect security therefor, (b) to advance or supply funds (i) for, the purchase or payment of any such primary obligation or (ii) to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the primary obligor, (c) to purchase property, securities or services primarily for the purpose of assuring the owner of any such primary obligation of the ability of the primary obligor to make payment of such primary obligation or (d) otherwise to assure or hold harmless the owner of such primary obligation against loss in respect thereof; provided, however, that the term Contingent Obligation shall not include endorsements of instruments for deposit or collection in the ordinary course of business. The amount of any Contingent Obligation shall be deemed to be an amount equal to the stated or determinable amount of the primary obligation in respect of which such Contingent Obligation is made or, if not stated or determinable, the maximum reason-ably anticipated liability in respect thereof (assuming such Person is required to perform thereunder) as determined by such Person in good faith.

     “ DGCL ” means the Delaware General Corporation Law, as amended from time to time.

     “ Employee Waivers ” means those Waivers of Certain Employment Agreement Entitlements, dated as of the Closing Date, executed and delivered by each of Mary Jane Johnson and Robert Landis, substantially final copies of each of which are attached as Exhibits C-1 and C-2, respectively.

     “ Employment Agreement Amendments ” means the amendments, dated as of the date of the Closing Date, to each of: (i) the employment agreement, dated as of February 7, 2003 and as amended to date, between the Company and Mary Jane Johnson, and (ii) the employment agreement, dated as of February 7, 2003 and as amended to date, between the Company and Robert Landis, substantially final copies of which are attached hereto as Exhibits D-1 and D-2, respectively.

     “ Environmental Law (s) ” means the Comprehensive Environmental Response, Compensation and Liability Act, the Resource Conservation and Recovery Act, the Clean Air Act, and the Clean Water Act, Solid Waste Disposal Act, Toxic Substance Control Act, Oil Pollution Act of 1990, and any other federal, state, local or foreign law, regulation or legal requirement relating to: (a) the release, containment, removal, remediation, response, cleanup or abatement of any Hazardous Material; (b) the manufacture, generation, formulation, processing, labeling, distribution, introduction into commerce, use, treatment, handling, storage, recycling, disposal or transportation of any Hazardous Material; (c) exposure of Persons to any Hazardous Material; (d) the physical structure, use or condition of a building, facility, fixture or other structure, including those relating to the management, use, storage, disposal, cleanup or removal of asbestos, asbestos-containing materials, poly-chlorinated biphenyls or any other Hazardous Material; (e) the pollution, protection or clean up of the environment; or (f) noise.

-3-

     “ Environmental Permit ” means any permit or authorization from any Governmental Authority required under, issued pursuant to, or authorized by any Environmental Law.

     “ ERISA ” means the Employee Retirement Income Security Act of 1974, as amended from time to time.

     “ Exchange Act ” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

     “ Financials ” means as defined in Section 3.7 of this Agreement.

     “ First Put Option ” means the right of the Company to issue and sell Common Shares to the Buyer in accordance with and subject to Section 5.1(a) of this Agreement.

     “ First Put Option Closing ” means the issuance and sale of the First Put Option Shares by the Company to the Buyer in accordance with Section 5.1(a) of this Agreement.

     “ First Put Option Shares ” means the Common Shares to be issued and sold by the Company to the Buyer at the First Put Option Closing in accordance with Section 5.1(a) of this Agreement.

     “ Funded Indebtedness ” means at a particular date, all Indebtedness, whether secured or unsecured, having a final maturity (or which by the terms thereof is renewable or extendable at the option of the obligor for a period ending) more than one year after the date of creation (or renewal or extension) thereof.

     “ FY 2006 ” means the fiscal year of the Company ending on May 31, 2006.

     “ FY 2007 ” means the fiscal year of the Company ending on May 31, 2007.

     “ GAAP ” means generally accepted accounting principles in the United States in effect from time to time.

     “ Governmental Authority ” means any nation or government, any state, local or other political subdivision thereof and any entity, department, authority, bureau, agency or commission exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government.

     “ Hazardous Material ” means any (i) pollutant, contaminant, chemical; (ii) industrial, solid, liquid or gaseous toxic or hazardous substance, material or waste, (iii) petroleum or any fraction or product thereof; (iv) asbestos or asbestos-containing material; (v) poly-chlorinated biphenyl; (vi) chlorofluorocarbons; and (vii) other substance, material or waste; any of which are regulated under any Environmental Law.

     “ Indebtedness ” of a Person, at a particular date, means (a) all indebtedness of such Person for borrowed money or for the deferred purchase price of property, (b) the face amount of all letters of credit issued for the account of such Person and, without duplication, all drafts drawn

-4-

thereunder, and (c) all Indebtedness of the type described in paragraph (a) or (b) of this definition secured by any Lien on any property owned by such Person, to the extent attributable to such Person’s interest in such property, even though such Person has not assumed or become liable for the payment thereof; but excluding trade and other accounts payable in the ordinary course of business in accordance with customary trade terms and which are not overdue for a period of more than sixty (60) days or, if overdue for more than sixty (60) days, as to which a dispute exists and adequate reserves in conformity with GAAP have been established on the books of such Person.

     “ Indemnified Person ” shall have the meaning given to such term in Article 8 of this Agreement.

     “ Indemnifier ” shall have the meaning given to such term in Article 8 of this Agreement.

     “ IRC ” or “ Internal Revenue Code ” means the Internal Revenue Code of 1986, as amended and the U.S. Treasury Department regulations promulgated thereunder.

     “ IRS ” means the U.S. Internal Revenue Service.

     “ Lease Obligations ” of the Company and its Significant Subsidiaries means, for any period, the rental commitments of the Company on a consolidated basis for such period, if any, under leases for real and/or Personal property (net of income from sub-leases thereof, but excluding taxes, insurance, maintenance and similar expenses which the lessee is obligated to pay under the terms of said leases), excluding however, obligations under leases which are classified as Indebtedness hereunder.

     “ Lien ” means any mortgage, pledge, hypothecation, assignment, security interest, lien, charge or encumbrance, or preference, priority or other security agreement or preferential arrangement of any kind or nature whatsoever (including, without limitation, any conditional sale or other title retention agreement, any financing lease having substantially the same economic effect as any of the foregoing, and the filing of, or agreement to give, any financing statement under the UCC or comparable law of any jurisdiction).

     “ Liquidation Preference ” means as defined in Section 3.1 of the Certificate of Designation.

     “ Material Adverse Effect ” means a material adverse change to the Company’s assets, business, prospects, liabilities, properties, condition (financial or otherwise) or results of operations.

     “ New Securities ” means shares of Common Stock and any other securities or rights convertible or exchangeable into shares of Common Stock; provided, however, that “New Securities” shall not include (i) Common Shares issued or issuable upon conversion of the Series A Preferred Shares, (ii) the Put Option Shares, (iii) securities issued in connection with any stock split, stock dividend or other recapitalization of the Company, (iv) equity securities and options to purchase equity securities issued to management, directors or employees of the Company pursuant to plans outstanding on the Closing Date, or any additional stock option plans approved by the Board of Directors or any class of holders of Preferred Stock or Common Stock, or (v)

-5-

Common Stock or other securities issued or issuable upon conversion of rights, options, warrants or convertible securities issued and outstanding prior to the Closing Date.

     “ Obligations ” means all indebtedness, liabilities and obligations of the Company to the Buyer, whether now existing or hereafter incurred, direct or indirect, absolute or contingent, secured or unsecured, matured or unmatured, whether for principal, interest, fees or otherwise, arising out of this Agreement.

     “ Permit ” means as defined in Section 3.10 of this Agreement.

     “ Person ” means any individual, corporation, partnership, limited liability partnership, limited liability company, joint venture, association, joint stock company, sole proprietorship, business trust, unincorporated organization or government or other agency or political subdivision thereof.

     “ Purchase Price ” means as defined in Section 2.2 of this Agreement.

     “ Preferred Stock ” means any class or series of Preferred Stock of the Company, par value $50.00 per share.

     “ Put Option Closings ” means, as may be used herein collectively from time to time, the First Put Option Closing, the Second Put Option Closing and the Variable Price Put Option Closing.

     “ Series A Preferred Shares ” has the meaning set forth in the recitals of this Agreement.

     “ Put Option Shares ” means, as may be used herein collectively from time to time, the First Put Option Shares, the Second Put Option Shares and the Variable Price Put Option Shares.

     “ Registration Rights Agreement ” means the registration rights agreement to be entered into between the Buyer and the Company on the Closing Date, a substantially final copy of which is attached as Exhibit E hereto.

     “ Requirements of Law ” means as to any Person, the Certificate of Incorporation and Bylaws or other organizational or governing documents of such Person, and any law, treaty, rule or final regulation, or final determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such Person or any of its assets or to which such Person or any of its assets is subject.

     “ Responsible Officer ” means the chief financial officer or the treasurer of the Company.

     “ SEC Reports ” means as defined in Section 3.7 of this Agreement.

     “ Second Put Option ” means the right of the Company to issue and sell Common Shares to the Buyer in accordance with and subject to Section 5.1(b) of this Agreement.

-6-

     “ Second Put Option Closing ” means the issuance and sale of the Second Put Option Shares by the Company to the Buyer in accordance with Section 5.1(b) of this Agreement.

     “ Second Put Option Shares ” means the Common Shares to be issued and sold by the Company to the Buyer at the Second Put Option Closing in accordance with Section 5.1(b) of this Agreement.

     “ Securities ” means, collectively, the Series A Preferred Shares (and the Common Shares issuable upon conversion of the Series A Preferred Shares) and the Put Option Shares issued at the Put Option Closings, all in accordance with the terms and conditions of this Agreement.

     “ Securities Act ” means the Securities Act of 1933, as amended and the rules and regulations promulgated thereunder.

     “ Securities Laws ” means the Securities Act, the Exchange Act, the Sarbanes-Oxley Act of 2002, and any applicable state securities laws.

     “ Significant Subsidiaries ” means Comprehensive Behavioral Care, Inc., Comprehensive Provider Network of Texas, Inc., Healthcare Management Services, Inc., Comprehensive Care Integration, Inc., Healthcare Management Services of Michigan, Inc., Comprehensive Behavioral Care of Connecticut, Inc., CompCare of Pennsylvania, Inc. and any other subsidiaries of the Company that constitute “Significant Subsidiaries” of the Company as that term is defined under Regulation S-X of the Exchange Act.

     “ Subsidiary, ” with respect to any Person, means (i) a corporation a majority of whose Capital Stock with voting power to elect directors is at the time, directly or indirectly, owned by such Person, by such Person and one or more subsidiaries of such Person or by one or more subsidiaries of such Person or (ii) any other Person (other than a corporation) in which such Person, one or more subsidiaries of such Person, or such Person and one or more subsidiaries of such Person, directly or indirectly, at the date of determination thereof has at least majority ownership interest.

     “ 2005 Stockholders’ Meeting ” means the meeting of the Company’s stockholders to be held in accordance with DGCL and the Company’s organizational documents and in connection with, among other things, the amendments to the Certificate of Incorporation and Bylaws required to be approved after the Closing and the election of directors of the Company contemplated by this Agreement, all as described in this Agreement.

     “ Tangible Property ” means as defined in Section 3.19 of this Agreement.

     “ Tax Settlement Agreement ” means that certain Offer in Compromise as amended on March 13, 2002 and accepted by the IRS on January 22, 2003, with respect to assessments relating to tax years 1985 and 1986, pursuant to which the Company paid a total of $2,257,949 in conditional settlement of its obligations thereunder, with the final installment of $2,167,949 being paid to the IRS on February 26, 2003, which settlement remains subject to the IRC’s rules and regulations.

- 7 -

     “ Variable Price Put Option ” means the right of the Company to issue and sell Common Shares to the Buyer in accordance with and subject to Section 5.1(c) of this Agreement.

     “ Variable Price Option Closing ” means the issuance and sale of the Variable Price Put Option Shares by the Company to the Buyer in accordance with Section 5.1(c) of this Agreement.

     “ Variable Price Put Option Shares ” means the Common Shares to be issued and sold by the Company to the Buyer at the Variable Price Put Option Closing in accordance with Section 5.1(c) of this Agreement.

ARTICLE 2

PURCHASE AND SALE

      Section 2.1 Authorization of the Series A Preferred Shares.

     The Company has authorized the sale and issuance to the Buyer of an aggregate of 14,400 Series A Preferred Shares having the designation, preferences, rights and privileges set forth in the Certificate of Designation.

      Section 2.2 Agreement to Purchase and Sell at the Closing.

     The Company hereby agrees to issue and sell to the Buyer, and the Buyer, in reliance upon the representations, warranties, covenants and agreements of the Company contained herein, and subject to the terms and conditions of this Agreement, hereby agrees to purchase from the Company, at the Closing, an aggregate of 14,400 Series A Preferred Shares at a price per share of $250.00, for an aggregate purchase price of $3,600,000 (the “Purchase Price”). Each Series A Preferred Share shall be convertible into 294.12 Common Shares, subject to adjustment as described herein and in the Certificate of Designation.

      Section 2.3 Payment of Purchase Price; Issuance of the Series A Shares.

     The consummation of the sale and purchase of the Series A Preferred Shares shall take place at the Closing at the offices of Holland & Knight LLP, at 10:00 a.m. (E.S.T.) on June 14, 2005, or at such other place, date and time as may be mutually agreed upon by the Company and the Buyer in writing. Upon the Buyer’s purchase of the Series A Preferred Shares at the Closing, the Company shall issue and deliver to the Buyer, against delivery of the Purchase Price therefor, a stock certificate or certificates in definitive form, registered in the name of the Buyer and representing ownership of the Series A Preferred Shares purchased at the Closing. As payment in full for the Series A Preferred Shares being purchased by it at the Closing, and against delivery of the stock certificate or certificates therefor on the Closing Date, the Buyer shall deliver to the Company by wire transfer, in immediately available funds, an amount of $3,600,000, to one or more accounts designated by the Company to the Buyer not fewer than two (2) days prior to the Closing.

- 8 -

ARTICLE 3

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

     The Company hereby represents and warrants, for itself and for its Significant Subsidiaries (or subsidiaries, as the case may be) as follows:

      Section 3.1 Organization; Good Standing, etc.

     Each of the Company and the Significant Subsidiaries is a duly organized and validly existing corporation under the jurisdiction of its incorporation, and their respective statuses are active under the laws of such jurisdictions Each of the Company and its Significant Subsidiaries has all requisite corporate power and corporate authority for the ownership and operations of its assets and for the conduct of its business as now conducted and as now proposed to be conducted. Each of the Company and its Significant Subsidiaries is duly qualified and is in good standing as a foreign corporation and authorized to do business in all jurisdictions wherein the character of the property owned or leased by it, or the nature of the activities conducted by it, makes such qualification or authorization necessary, except where the failure to so qualify or be so authorized would not have a Material Adverse Effect.

      Section 3.2 Authority to Execute and Perform Agreements.

     The Company has all requisite corporate power and corporate authority to execute and deliver the Basic Documents and to perform all its obligations thereunder, and to issue, sell and deliver the Series A Preferred Shares and the Common Shares issuable under this Agreement. The Company has the full legal right and power and all authority and approval required to enter into, execute and deliver the Basic Documents and to perform fully the Company’s obligations thereunder. Each of the Basic Documents has been duly executed and delivered and constitutes the valid and binding obligation of the Company enforceable against it in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally or the effect of general principles of equity. No approval or consent of any Governmental Authority, and (except as otherwise specified in this Agreement or any Schedule hereto or except as delivered at the Closing) no approval or consent of any other Person, is required in connection with the execution and delivery by the Company of the Basic Documents and the consummation and performance by the Company of the transactions contemplated thereby. The execution and delivery of the Basic Documents, the consummation of the transactions contemplated under the Basic Documents, and the performance by the Company of the Basic Documents in accordance with their respective terms and conditions will not conflict with or result in the breach or violation of any of the terms and conditions of, or constitute (or with notice or lapse of time or both would constitute) a default under, (i) the Certificate of Incorporation or Bylaws of the Company; (ii) any instrument, contract or other agreement by or to which the Company is a party or by or to which it or its assets or properties are bound or subject; (iii) any statute or any regulation, order, judgment or decree of any Governmental Authority; or (iv) any Permit.

- 9 -

      Section 3.3 Capitalization.

     Upon the filing of the Certificate of Designation, the authorized capital stock of the Company shall consist of: (i) 12,500,000 shares of Common Stock, and (ii) 14,400 shares of Preferred Stock, all of which have been designated Series A Preferred Shares. Schedule 3.3 sets forth a capitalization table of the Company on a fully-diluted, post-Closing basis. Immediately prior to the Closing, 5,582,547 shares of Common Stock will be issued and outstanding, and no Series A Preferred Shares will be issued and outstanding. All issued and outstanding shares of Common Stock and all issued and outstanding shares of the capital stock of each of the Subsidiaries are duly authorized and validly issued, and are fully paid and non-assessable. Following receipt of payment pursuant to Section 2.3 or Sections 5.1(a), 5.1(b) and 5.1(c) hereof (as the case may be), all Securities issuable in connection with the transactions contemplated hereby will be duly authorized and validly issued, and will be fully paid and non-assessable. The designations, powers, preferences, rights, qualifications, limitations and restrictions in respect of the Series A Preferred Shares will be as set forth in the Certificate of Designation, and all such designations, powers, preferences, rights, qualifications, limitations and restrictions are in accordance with all applicable laws and are legal, valid and binding obligations of the Company, enforceable in accordance with their terms except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of general application affecting enforcement of creditors’ rights generally, or (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies. Except as set forth on Schedule 3.3, no subscription, warrant, option, convertible security or other right (contingent or other) to purchase or otherwise acquire from the Company (or, to the best of the Company’s knowledge, from any other Person) any equity securities of the Company is authorized or outstanding, and (ii) there are no additional commitments by the Company to issue shares, subscriptions, warrants, options, convertible securities or other such rights or to distribute to holders of any of its equity securities any evidence of indebtedness or assets. Schedule 3.3 sets forth, accurately and completely, the number of options granted under the 1995 Incentive Compensation Plan, the 2002 Incentive Compensation Plan and the Directors’ Compensation Plan, as well as the date of grant, the exercise price and the vesting schedules of all such options granted. Except as provided for in the Certificate of Designation or as set forth on Schedule 3.3, the Company has no obligation to purchase, redeem or otherwise acquire any of its equity securities or any interest therein or to pay any dividend or make any other distribution in respect thereof. Except as set forth on Schedule 3.3, to the best of the Company’s knowledge, there are no voting trusts or agreements, shareholders’ agreements, pledge agreements, buy-sell agreements, rights of first refusal, preemptive rights (statutory or contractual) or proxies relating to any securities of the Company (where the Company is not a party thereto). There are no restrictions on the transfer of shares of capital stock of the Company, other than those imposed by relevant federal and state securities laws. The issuance of the Series A Preferred Shares and the Common Shares issuable upon conversion thereof will not result in any adjustment under the antidilution or exercise rights of any holders of any outstanding shares of capital stock, options, warrants or other rights to acquire any security of the Company, except under the indenture for the Company’s 7-1/2% convertible subordinated debentures and the 1995 Incentive Compensation Plan. The offer and sale of all shares of Common Stock and other securities of the Company

- 10 -

issued before the Closing hereunder complied with or were exempt from applicable Securities Laws.

      Section 3.4 Consents and Approvals.

     Except as set forth on Schedule 3.4 and as otherwise expressly set forth in this Agreement, no authorization, consent, approval, license, filing or registration with any Governmental Authority or Person is or will be necessary for the valid execution, delivery and performance by the Company of the Basic Documents, the issuance, sale and delivery of the Securities, other than filings pursuant to the Securities Laws (all of which filings have been made or will be made by the Company) in connection with the sale of the Securities.

      Section 3.5 Subsidiaries.

     Schedule 3.5 sets forth a complete and accurate list of all subsidiaries of the Company, showing as to each such subsidiary, the jurisdiction of its incorporation. Except as set forth on Schedule 3.5, all of such subsidiaries are either directly wholly owned by the Company, or by or through subsidiaries of the Company.

      Section 3.6 Certificate of Incorporation and Bylaws.

     The Certificate of Incorporation and Bylaws of the Company, and all amendments to each to date, copies of all of which have been delivered to the Buyer, are true, correct and complete.

      Section 3.7 SEC Reports; Financial Statements.

     (a) The Company has delivered or made available to the Buyer true and complete copies of all periodic and current reports, statements and other documents that the Company has filed under the Exchange Act since May 31, 2004 (collectively, the “SEC Reports”), each in the form (including exhibits and any amendments thereto) required to be filed with the SEC. As of their respective dates, each of the SEC Reports (i) complied in all material respects with all applicable requirements of the Securities Laws, (ii) were filed in a timely manner, and (iii) did not contain any false or untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. None of the Significant Subsidiaries is required to file any forms, reports or other documents with the SEC.

     (b) The audited consolidated financial statements (including the notes thereto) of the Company and its Subsidiaries for the fiscal year ended May 31, 2004 contained in the Company’s Annual Report on Form 10-K for such fiscal year and the unaudited consolidated financial statements (including the notes thereto) of the Company and its Subsidiaries for the fiscal quarter ended February 28, 2005 contained in the Company’s Quarterly Report on 10-Q for such fiscal quarter (collectively, the “Financials”) present fairly, in all material respects, the financial position of the Company and its Subsidiaries on a consolidated basis as of the dates thereof and its results of operations for the periods covered thereby (subject, in the case of unaudited financial statements, to normal year-end audit adjustments), and the Financials have been prepared in accordance with GAAP consistently applied and in accordance with Regulation S-X (except (i) as

- 11 -

may be otherwise set forth in such Financials or (ii) in the case of unaudited financial statements, to the extent they may not include footnotes or may be consolidated or summary statements). Except as and to the extent set forth (or incorporated by reference) in such Quarterly Report on Form 10-Q or except as set forth on Schedule 3.8, (i) neither the Company nor any of its Subsidiaries has any material liabilities, contingent or otherwise, other than (a) liabilities incurred in the ordinary course of business since the Balance Sheet Date, and (b) obligations under contracts and commitments incurred in the ordinary course of business and not required under GAAP to be reflected in the Financials; (ii) there has been no material adverse change in the assets, business, liabilities, properties, prospects, condition (financial or otherwise) or results of operations of the Company or any of the Subsidiaries; (iii) neither the business, condition or operations of the Company or any of the Subsidiaries nor any of their properties or assets has been materially or adversely affected as a result of any legislative or regulatory change, any revocation or change in any franchise, license or right to do business, or any other event or occurrence, whether or not insured against; and (iv) neither the Company nor any of its Subsidiaries has entered into any transaction outside of the ordinary course of business or made any distribution on its capital stock or other ownership interest.

      Section 3.8 No Material Adverse Change.

     Since the Balance Sheet Date, except as set forth on Schedule 3.8 hereto, there has been no material adverse change in the assets, properties, operations, prospects, business or condition (financial or otherwise) of the Company, and the Company does not know of any such change which is threatened, nor has there been any damage, destruction or loss materially affecting the assets, properties, prospects, business or condition of the Company, whether or not covered by insurance.

      Section 3.9 Tax Matters.

     The Company has filed all tax returns, statements, reports and forms required to be filed by it and has paid or caused to be paid all taxes shown thereon to be due for the periods covered thereby, including interest and penalties, or has provided reserves for payment thereof to the extent required under GAAP. The charges, accruals and reserves on the books of the Company in respect of taxes and other governmental charges are adequate to cover the tax liabilities accruing with respect to or payable by the Company with respect to any tax return of the Company. There is no action, suit, proceedings, investigation, audit or claim now pending or to the Company’s knowledge, proposed, relating to any tax due with respect to any tax return of the Company, and there are no liens for taxes upon the assets of the Company except liens for current taxes not yet due. The Company has made all payments and has taken any and all actions on a timely basis required under, and is in compliance with, the Tax Settlement Agreement, and the Company has incurred no additional liabilities thereunder.

      Section 3.10 Compliance with Laws.

     There is no (i) action, suit, claim, proceeding or investigation pending or involving or, to the best of the Company’s knowledge, threatened against or affecting the Company or any Significant Subsidiary, at law or in equity, or before or by any Governmental Authority;

- 12 -

(ii) arbitration proceeding relating to the Company or any Significant Subsidiary pending under collective bargaining agreements or otherwise; or (iii) governmental inquiry pending or, to the best of the Company’s knowledge, threatened, against or affecting the Company or any Significant Subsidiary (including, without limitation, any inquiry as to the qualification of the Company or any Significant Subsidiary to hold or receive any license or permit), and, to the best of the Company’s knowledge, there is no reasonable basis for any of the foregoing. Neither the Company nor any of its Significant Subsidiaries is in default with respect to any order, writ, judgment, injunction or decree of any Governmental Authority known to the Company or served upon the Company or any Significant Subsidiary of any court or of any federal, state, municipal or other governmental department, commission, board, bureau, agency or instrumentality, domestic or foreign. There is no action or suit by the Company or any Significant Subsidiary pending or threatened against others. The Company and each Significant Subsidiary has complied in all material respects with all laws, rules, regulations and orders applicable to its business, operations, properties, assets and services, and the Company and each Significant Subsidiary has all necessary Permits, licenses and other authorizations required to conduct its business as currently conducted. There is no existing law, rule, regulation or order, and the Company is not aware of any proposed law, rule, regulation or order, that would prohibit or materially restrict the Company or any Significant Subsidiary from, or otherwise materially adversely affect the Company or any Significant Subsidiary in, conducting its business in any jurisdiction in which it is now conducting business. Schedule 3.10 lists accurately and completely all licenses, permits, authorizations, orders or approvals of any Governmental Authority that are material to or necessary for the conduct of the business of the Company (collectively the “Permits”). Except as set forth on Schedule 3.10, all Permits are in full force and effect, and no violations are or have been recorded in respect of any Permit, and no proceeding is pending, or to the knowledge of the Company, threatened, to revoke or limit any Permit. Except as set forth on Schedule 3.10, the Company does not know of any dispute with any Person under contract with the Company which could adversely affect, the Company’s assets, properties, business or condition. The Company does not know of any present or threatened walkout, strike or any other similar occurrence which materially and adversely affects, or may materially and adversely affect, the assets, properties, business or condition of the Company or of any attempt to organize or represent the labor force of the Company.

      Section 3.11 No Pending Transactions.

     Except for the transactions contemplated by this Agreement and except as set forth on Schedule 3.11 hereto, neither the Company nor any Significant Subsidiary is a party to or bound by or the subject of any agreement, undertaking, commitment or discussions or negotiations with any Person that could result in (i) the sale, merger, consolidation or recapitalization of the Company or any Significant Subsidiary, (ii) the sale of all or substantially all of the assets of the Company or any Significant Subsidiary in one or a series of transactions, or (iii) a change of control of more than 5% of the outstanding capital stock of the Company or any Significant Subsidiary.

- 13 -

      Section 3.12 Brokers’ Fees.

     The Company has not, directly or indirectly, incurred any liability for brokerage or finders’ fees in connection with this Agreement.

      Section 3.13 Proprietary Information of Third Parties.

     Except as set forth on Schedule 3.13, to the best of the Company’s knowledge, no third party has claimed or has reason to claim that any Person employed by or affiliated with the Company or any Significant Subsidiary has (a) violated or may be violating to any material extent any of the terms or conditions of his employment, non-competition or non-disclosure agreement with such third party, (b) disclosed or may be disclosing or utilized or may be utilizing any trade secret or proprietary information or documentation of such third party, or (c) interfered or may be interfering in the employment relationship between such third party and any of its present or former employees, or has requested information from the Company or any Significant Subsidiary which suggests that such a claim might be contemplated. To the best of the Company’s knowledge, no Person employed by or affiliated with the Company or any Significant Subsidiary has utilized or proposes to utilize any trade secret or any information or documentation proprietary to any former employer, and to the best of the Company’s knowledge, no Person employed by or affiliated with the Company or any Significant Subsidiary has violated any confidential relationship which such Person may have had with any third party, in connection with the development, manufacture or sale of any product or proposed product or the development or sale of any service or proposed service of the Company or any Significant Subsidiary, and the Company has no reason to believe there will be any such employment or violation. To the best of the Company’s knowledge, none of the execution or delivery of this Agreement or the other Basic Documents, or the carrying on of the business of the Company as officers, employees or agents by any officer, director or key employee of the Company or any Significant Subsidiary, or the conduct or proposed conduct of the business of the Company and each Significant Subsidiary, will materially conflict with or result in a material breach of the terms, conditions or provisions of or constitute a material default under any contract, covenant or instrument under which any such Person is obligated.

      Section 3.14 Agreements.

     Schedule 3.14 sets forth all of the following contracts and other agreements, whether written or oral, to which the Company or any Significant Subsidiary is a party or by or to which it or its assets or properties are bound or subject with respect to which the Company or Significant Subsidiary may have any obligations to pay, or the right to receive, in each case, in excess of $25,000 over a twelve-month period: (i) contracts and other agreements with any current or former officer, director, employee, consultant or shareholder; (ii) agreement with any labor union or association representing any employee; (iii) contracts and other agreements for the purchase, sale or other acquisition of materials, supplies, equipment, merchandise or services; (iv) representative, management, marketing, sales agency, printing or advertising agreements; (including without limitation, all contracts with customers, providers, Governmental Authorities, health maintenance organizations and similar Persons), (v) contracts and other agreements for the sale of any of its assets or properties other than in the ordinary course of business or for the grant

- 14 -

to any Person of any preferential rights to purchase any of its assets or properties; (vi) joint venture agreements relating to the assets, properties or business of the Company or Significant Subsidiary or by or to which it or its assets or properties are bound or subject; (vii) contracts or other agreements under which it agrees to indemnify any party, to share the tax liability of any party or to refrain from competing with any party; or (viii) any other contract or other agreement, whether or not made in the ordinary course of business. All of the contracts and other agreements set forth on Schedule 3.14 are in full force and effect and the Company or Significant Subsidiary has paid in full or accrued all amounts due thereunder, and has satisfied in full or provided for all of its liabilities and obligations thereunder, and, except as set forth on Schedule 3.14, is not in default under any of them, nor is any other party to any such contract or other agreement in default thereunder, nor does any condition exist which with notice or lapse of time or both would constitute a default thereunder. No approval or consent of any Person is needed in order that the contracts or other agreements set forth on Schedule 3.14 and other Schedules hereto continue in full force and effect following the consummation of the transactions contemplated by the Basic Documents.

     The Company, each Significant Subsidiary, and, to the best of the Company’s knowledge, each other party thereto, have performed all the obligations required to be performed by them to date, have received no notice of default and are not in default (with due notice or lapse of time or both) under any lease, agreement or contract now in effect to which the Company or any Significant Subsidiary is a party or by which it or its property may be bound. Neither the Company nor any Significant Subsidiary has a present expectation or intention of not fully performing all its obligations under each such lease, contract or other agreement, and neither the Company nor any Significant Subsidiary has knowledge of any breach or anticipated breach by the other party to any contract or commitment to which the Company or any Significant Subsidiary is a party.

      Section 3.15 Real Estate.

     Neither the Company nor any Significant Subsidiary owns real property. Schedule 3.15 sets forth a list and summary description of (i) all leases, subleases or other agreements under which the Company is lessor or lessee of any real property; or (ii) all options held by the Company or any Significant Subsidiary or contractual obligations on the part of the Company or Significant Subsidiary to purchase or acquire, or sell or dispose of, any interest in real property. Such leases, subleases, options and other agreements are in full force and effect, the Company has not received any notice of any default thereunder and the Company has delivered to the Buyer at the Closing true and complete copies of all such leases, subleases and other agreements. The Company’s leasehold interests are subject to no lien or other encumbrance and enjoy a right of quiet possession against any Lien on the property.

      Section 3.16 Accounts and Notes Receivable.

     All accounts and notes receivable reflected on the Financials and all accounts and notes receivable arising subsequent to the Balance Sheet Date, have arisen in the ordinary course of business, represent valid obligations to the Company and, subject only to consistently recorded reserves for bad debts, have been collected or are collectible in the aggregate recorded amounts

- 15 -

thereof in accordance with their terms. All items which are required by GAAP to be reflected as accounts and notes receivable on the Financials and on the books of the Company are so reflected.

      Section 3.17 Certain Healthcare Regulatory Matters.

     (a) Except as set forth on Schedule 3.17, to the Company’s knowledge (for the purposes of this Section 3.17 only, “knowledge” means the actual or imputed knowledge of Mary Jane Johnson or Robert Landis after due inquiry reasonable under the circumstances), none of the Company, the Subsidiaries or any of their respective officers, directors or employees (within the meaning of 42 U.S.C. (§ 1320a-5(b)) has engaged in any activities which constitute violations of, or are cause for imposition of civil penalties upon the Company or the Subsidiaries or mandatory or permissive exclusion of such Persons from Medicare or Medicaid, under §§ 1320a-7, 1320a-7a, 1320a-7b, or 1395nn of Title 42 of the United States Code, the federal Civilian Health and Medical Plan of the Uniformed Services Statute (“CHAMPUS”), any other state or federal health care program, or the regulations promulgated pursuant to such statutes or regulations or related state or local statutes or which constitute violations of or deficiencies under the standards of any private accrediting organization from which the Company or the Subsidiaries is accredited or seeks accreditation, including the following activities:

          (i) making or causing to be made a false statement or representation of a material fact in any application for any benefit or payment;

          (ii) making or causing to be made any false statement or representation of a material fact for use in determining rights to any benefit or payment;

          (iii) presenting or causing to be presented a claim for reimbursement under CHAMPUS, Medicare, Medicaid or any other state healthcare program or federal healthcare program that is (A) for an item or service that the Person presenting or causing to be presented knows or should know was not provided as claimed, or (B) for an item or service where the Person presenting knows or should know that the claim is false or fraudulent;

          (iv) offering, paying, soliciting or receiving any remuneration (including any kickback, bribe or rebate), directly or indirectly, overtly or covertly, in cash or in kind (A) in return for referring, or to induce the referral of, an individual to a Person for the furnishing or arranging for the furnishing of any item or service for which payment may be made in whole or in part by CHAMPUS, Medicare or Medicaid, or any other state healthcare program or any federal healthcare program, or (B) in return for, or to induce, the purchase, lease, or order, or the arranging for or recommending of the purchase, lease, or order, of any good, facility, service, or item for which payment may be made in whole or in part by CHAMPUS, Medicare or Medicaid or any other state healthcare program or any federal healthcare program;

          (v) making or causing to be made or inducing or seeking to induce the making of any false statement or representation (or omitting to state a material fact required to be stated therein or necessary to make the statements contained therein not misleading) of a material fact with respect to (A) the conditions or operations of a facility in order that the facility may qualify

- 16 -

for CHAMPUS, Medicare, Medicaid or any other state healthcare program certification or any federal healthcare program certification, or (B) information required to be provided under § 1124(A) of the Social Security Act (“ SSA ”) (42 U.S.C. § 1320a-3); or

          (vi) failing substantially to provide medically necessary items or services, if the failure adversely affects individuals covered by Medicare or Medicaid.

      Section 3.18 Tangible Property.

     The Company and each Significant Subsidiary has valid and marketable title to all of its assets now carried on its books including those reflected on the Balance Sheet, or acquired since the Balance Sheet Date (except personal property disposed of since said date in the ordinary course of business) free of any Liens, except such Liens that arise in the ordinary course of business and do not materially impair the Company’s ownership or use of such property or assets. The Company and each Significant Subsidiary is in compliance under all leases for property and assets under which it is operating, and all said leases are valid and subsisting and are in full force and effect. Schedule 3.18 sets forth all interests, in excess of $10,000, owned or claimed by the Company (including, without limitation, options) in or to the machinery, equipment, furniture, leasehold improvements, fixtures, vehicles, structures, any related capitalized items and other tangible property material to the business of the Company and which is treated by the Company as depreciable or amortizable property (“Tangible Property”) not reflected on the Balance Sheet and not sold or disposed of in the ordinary course of business since the Balance Sheet Date. All material leases, conditional sale contracts, franchises or licenses pursuant to which the Company may hold or use any interest owned or claimed by it (including, without limitation, options) in or to Tangible Property are in full force and effect and, as respects the Company’s performance, there is no default or event of default or event which with notice or lapse of time or both would constitute a default. The Tangible Property of the Company currently used in its business is in good operating condition and repair, and the Company has received no notice that any of it is in violation of any existing law or any building, zoning, health, safety or other ordinance, code or regulation. During the past three years there has not been any significant interruption of the Company’s operations due to inadequate maintenance of the Tangible Property.

      Section 3.19 Intangible Property.

     Schedule 3.19 sets forth all patents, trademarks, service marks, trade names, franchises and software and financial reporting systems, all applications for any of the foregoing, and all permits, grants and licenses or other rights running to or from the Company relating to any of the foregoing which are material to its business. The rights of the Company in the property set forth on Schedule 3.19 are free and clear of any Liens. The Company has no notice of any adversely held patent, invention, trademark, service mark or trade name of any other Person or notice of any claim of any other Person relating to any of the property set forth on Schedule 3.19 or any process or confidential information of the Company, and the Company does not know of any basis for any such charge or claim.

- 17 -

      Section 3.20 Medicare/Medicaid Participation.

          (a) To the Company’s knowledge (for the purposes of this Section 3.20 only, “knowledge” means the actual or imputed knowledge of Mary Jane Johnson or Robert Landis after due inquiry reasonable under the circumstances), none of the Company, the Subsidiaries or any of their respective officers, directors or employees (as defined in SSA § 1126(b) or any regulations promulgated thereunder): (x) have had a civil monetary penalty assessed against him, her or it under § 1128A of the SSA or any regulations promulgated thereunder; (y) have been excluded from participation under the Medicare program or a state health care program as defined in SSA § 1128(h) or any regulations promulgated thereunder (“State Health Care Program”) or a federal health care program as defined in SSA § 1128B(f) (“Federal Health Care Program”); or (z) have been convicted (as that term is defined in 42 C.F.R. § 1001.2) of any of the following categories of offenses as described in SSA §§ 1128(a) and (b)(1), (2), (3) or any regulations promulgated thereunder:

          (i) criminal offenses relating to the delivery of an item or service under Medicare or any State Health Care Program or any Federal Health Care Program;

          (ii) criminal offenses under federal or state law relating to patient neglect or abuse in connection with the delivery of a health care item or service;

          (iii) criminal offenses under federal or state law relating to fraud, theft, embezzlement, breach of fiduciary responsibility, or other financial misconduct in connection with the delivery of a health care item or service or with respect to any act or omission in a program operated by or financed in whole or in part by any federal, state or local governmental agency;

          (iv) federal or state laws relating to the interference with or obstruction of any investigation into any criminal offense; or

          (v) criminal offenses under federal or state law relating to the unlawful manufacture, distribution, prescription or dispensing of a controlled substance.

      Section 3.21 Environmental Matters.

     (a) Except as disclosed in Schedule 3.21, each of the Company and the Significant Subsidiaries:

	(i)		is and has been in compliance with all applicable Environmental Laws;
	(ii)		has not been, and is not required to obtain any Environmental Permits for the continued conduct of the its business in the manner now conducted and presently proposed to be conducted;
	(iii)		does not generate or use any Hazardous Material in its operations or in the conduct of its business;
	(iv)		has never stored, disposed or released any Hazardous Material in or at any present or prior on-site or off-site facility;

- 18 -

	(v)		has not received or is subject to, or within the past three years has been subject to, any outstanding order, decree, judgment, complaint, agreement, claim, citation, or notice indicating, or is subject to any ongoing judicial or administrative proceeding claiming that any of the Companies, or the past and present assets of such Company are or may be: (A) in violation of any Environmental Law, (B) responsible for the on-site or off-site storage or release of any Hazardous Material, or (C) liable for any environmental liabilities and costs; and
	(vi)		has never used, owned or operated any underground storage tanks for storage of Hazardous Material.

     (b) Schedule 3.21 lists all environmental audits, inspections, assessments, investigations or similar reports relating to the business of the Company and its Significant Subsidiaries or the compliance of the same with applicable Environmental Laws.

     (c) Except as disclosed in Schedule 3.21:

	(i)		There are no past or present events, conditions or circumstances, including, without limitation, that are likely to interfere with or otherwise affect the business of the Company or the Significant Subsidiaries in the manner now conducted or which would interfere with compliance with any Environmental Law or Environmental Permit;
	(ii)		There are no circumstances or conditions present at or arising out of the present or former assets, properties, leaseholds, businesses or operations of the Companies in respect of off-site or on-site storage, transportation or disposal of, or any off-site or on-site release of, a Hazardous Substance which reasonably may be expected to give rise to any environmental liabilities and costs;
	(iii)		None of the present or past assets, properties, businesses, leaseholds or operations of the Company or the Significant Subsidiaries has received or is subject to, or within the past three years has been subject to, any outstanding order, decree, judgment, complaint, agreement, claim, citation, or notice or is subject to any ongoing judicial or administrative proceeding indicating that the past and present assets of any of the Company or the Significant Subsidiaries are or may be: (A) in violation of any Environmental Law; (B) responsible for the on-site or off-site storage or release of any Hazardous Substance; or (C) liable for any environmental liabilities and costs; or
	(iv)		The Company has no any reason to believe that any of the Company or the Significant Subsidiaries will become subject to a matter identified in subsection (iii); and, no investigation or review with respect to such

- 19 -

matters is pending or threatened, nor has any governmental authority or other third-party indicated an intention to conduct the same.

          (d) For purposes of this Section 3.21 only, all references to the “Company and the Significant Subsidiaries” are intended to include any and all other entities to which any of the Companies legally may be determined by a governmental authority to be liable as a successor under applicable Environmental Laws.

      Section 3.22 Other Offerings Subject to Integration.

     Neither the Company nor any Person acting on its behalf has taken or will take any other action (including, without limitation, any offer, issuance or sale of any security of the Company or any Significant Subsidiary under circumstances which might require the integration of such security with Series A Preferred Shares under the Securities Act or the rules and regulations of the SEC thereunder), in either case so as to subject the offering, issuance or sale of the Series A Preferred Shares to the registration provisions of the Securities Act.

      Section 3.23 Significant Customers or Suppliers.

     Except as set forth on Schedule 3.23, no single customer or supplier is of material importance (for purposes of this Section 3.23, “material” or words to such effect means amounting to more than 5% of the value of the goods or services provided by or to the Company or any of its Significant Subsidiaries). The relationships of the Company and the Significant Subsidiaries with its customers and suppliers are good commercial working relationships and, except as set forth on Schedule 3.23, no customer or supplier of the Company has cancelled or otherwise terminated, or threatened in writing to cancel or otherwise terminate, its relationship with the Company or has during the last 12 months decreased materially, or threatened to decrease or limit materially, its services, supplies or materials to the Company or the Significant Subsidiaries. Neither the Company nor any Significant Subsidiary has any notice that any such customer or supplier intends to cancel or otherwise modify its relationship with the Company or any Significant Subsidiary or to decrease materially or limit its business with the Company or any Significant Subsidiary.

      Section 3.24 ERISA.

     Schedule 3.24 sets forth all of the employee benefit plans of the Company (the “ Benefit Plans ” ). Except as set forth on Schedule 3.24 or as set forth in the employment agreements between the Company and its executive officers, the Company and the Significant Subsidiaries do not maintain or have any obligation to contribute to or any other liability with respect to or under (including but not limited to current or potential withdrawal liability), nor have they ever maintained or had any obligation to contribute to or any other liability with respect to or under: (i) any plan or arrangement, whether or not terminated, which provides medical, health, life insurance or other welfare types benefits for current or future retired or terminated employees (except for limited continued medical benefit coverage required to be provided under Section 4980B of the IRC or as required under applicable state law); (ii) any “multiemployer plan” (as defined in Section 3(37) of the Employee Retirement Income Security Act of 1974, as amended ( “ ERISA ” );

- 20 -

(iii) any employee plan which is a tax-qualified “defined benefit plan” (as defined in Section 3(35) of ERISA), whether or not terminated; (iv) any employee plan which is tax-qualified “defined contribution plan” (as defined in Section 3(34) of ERISA), whether or not terminated; or (v) except as set forth on Schedule 3.24, any other plan or arrangement providing benefits to current or former employees, including any bonus plan, plan for deferred compensation, employee health or other welfare benefit plan or other arrangement, whether or not terminated. For purposes of this Section 3.24 , the term “Company” includes all organizations under common control with the Company pursuant to Section 414(b) or (c) of the IRC. Each Benefit Plan has been administered in accordance with its terms and all applicable laws, rules or regulations . No Benefit Plan established or maintained, or to which contributions have been made, by the Company or any Subsidiary, which is subject to Part 3 of Subtitle B of Title I of ERISA had an accumulated funding deficiency (as such term is defined in Section 302 of ERISA) as of the last day of the most recent fiscal year of such plan ended prior to the date hereof, and no material liability to the Pension Benefit Guaranty Corporation has been incurred with respect to any such plan by the Company or any Significant Subsidiary.

      Section 3.25 Insurance.

     The Company and its Significant Subsidiaries maintain insurance (including, without limitation, directors and officers liability insurance covering each of the Company’s directors in an amount not less than $2,000,000 in the annual aggregate) of the type and in the amount described in Schedule 3.25 covering their respective properties and business are in compliance with all material requirements and provisions thereof. Such insurance coverage is customary and adequate in amount, type and scope for such properties and business. Neither the Company nor any Significant Subsidiary has received a notice of cancellation or non-renewal of any such policy or binder and none of them has any knowledge of any inaccuracy in any application for such policies or binders, any failure to pay premiums when due or any similar state of facts which might form the basis for termination of any such insurance. The Company maintains, and has maintained during the past seven years, directors and officers liability insurance in an amount and on terms reasonable under the circumstances in which it conducts its business and as a public company.

      Section 3.26 Officers, Directors and Employees.

     Schedule 3.26 sets forth the name and total compensation of each officer and director of the Company, and of each employee, consultant or agent of the Company, whose current annual rate of compensation (including bonuses and commissions) exceeds $30,000. No such officer or employee has advised the Company in writing that he intends to terminate employment with the Company. Except as set forth on Schedule 3.26, the Company and each Subsidiary has complied in all material respects with all applicable laws relating to the employment of labor, including provisions relating to wages, hours, equal opportunity, collective bargaining and the payment of Social Security and other taxes.

- 21 -

      Section 3.27 Operations of the Company.

     Except as set forth on Schedule 3.27 or as contemplated by this Agreement, from the Balance Sheet Date through the date hereof, neither the Company nor any Significant Subsidiary has:

     (i) amended its Certificate of Incorporation or Bylaws or merged with or into or consolidated with any other Person, or changed or agreed to change in any manner the character of its business;

     (ii) entered into or amended any employment agreement, entered into any agreement with any labor union or association representing any employee or entered into or amended any Benefit Plan;

     (iii) except for short-term bank borrowings in the ordinary course of business, incurred any Indebtedness;

     (iv) declared or paid any dividends or declared or made any distributions of any kind to its stockholders;

     (v) reduced its cash or short-term investments or their equivalent, other than to meet cash needs arising in the ordinary course of business, consistent with past practices;

     (vi) waived any right of material value to its business;

     (vii) made any change in its accounting methods or practices or made any change in depreciation or amortization policies or rates adopted by it;

     (viii) materially changed any of its business policies, including, without limitation, advertising, marketing, pricing, purchasing, personnel, sales, returns, budget or product acquisition policies;

     (ix) made any wage or salary increase or bonus, or increase in any other direct or indirect compensation, for or to any officer, director or employee of the Company, or any accrual for or commitment or agreement to make or pay the same, other than to Persons not officers, directors or stockholders of the Company made in the ordinary course of business;

     (x) made any loan or advance to any of its officers, directors, employees, consultants, agents or stockholders, other than travel advances made in the ordinary course of business;

     (xi) made any payment or commitment to pay any severance or termination pay to any of its officers, directors, employees, consultants or agents, other than to Persons not officers, directors or stockholders of the Company made in the ordinary course of business;

     (xii) except in the ordinary course of business: entered into any lease (as lessor or lessee); sold, abandoned or made any other disposition of any of its assets or properties;

- 22 -

granted or suffered any lien or other encumbrance on any of its assets or properties; entered into or amended any contract or other agreement to which it is a party or by or to which it or its assets or properties are bound or subject or pursuant to which it agrees to indemnify any party or refrain from competing with any party;

     (xiii) except in the ordinary course of business, incurred or assumed any debt, obligation or liability (whether absolute or contingent and whether or not currently due and payable);

     (xiv) except for inventory or equipment acquired in the ordinary course of business, made any acquisition of all or any part of the assets, properties, capital stock or business of any other Person; or

     (xv) except in the ordinary course of business, entered into any other material contract or other agreement or other material transaction.

      Section 3.28 Potential Conflicts of Interest.

     Except as set forth on Schedule 3.28, no officer or director of the Company (i) owns, directly or indirectly, any interest in (except not more than 5% stock holdings for investment purposes in securities of publicly-held and traded companies) or is an officer, director, employee or consultant of any Person which is a competitor, lessor, lessee, customer or supplier of the Company; (ii) owns, directly or indirectly, in whole or in part, any copyright, trademark, trade name, service mark, franchise, patent, invention, permit, license or secret or confidential information which the Company is using or the use of which is necessary for the business of the Company; or (iii) has any cause of action or other claim whatsoever against, or owes any amount to, the Company, except for claims in the ordinary course of business, such as for accrued vacation pay, accrued benefits under Benefit Plans and similar matters and agreements existing on the date hereof.

      Section 3.29 Full Disclosure.

     All documents and other information prepared and delivered by the Company and its representatives in connection with the Basic Documents and the transactions contemplated thereby are true, complete and authentic. The written information furnished by the Company and its representatives to the Buyer in connection with the Basic Documents and the transactions contemplated hereby and thereby does not contain any untrue statement of a material fact and does not omit to state any material fact necessary to make the statements made, in the context in which made, not false or misleading. There is no fact which the Company has not disclosed to the Buyer in writing which materially adversely affects, or so far as the Company can now reasonably foresee will materially adversely affect, the business or condition (financial or other) of the Company or the ability of the Company to perform the Basic Documents. Except for the representations and warranties set forth in this Article 3 or in the other Basic Documents, the Company, for itself or on behalf of any of its subsidiaries, has not made any representation or warranty, express or implied.

- 23 -

ARTICLE 3A

REPRESENTATIONS OF THE BUYER

     The Buyer hereby represents, warrants and acknowledges to the Company as follows:

      Section 3A.1 Organization; Good Standing, Etc.

     The Buyer is a limited liability company duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite power and authority to execute, deliver and perform its obligations under this Agreement.

      Section 3A.2 Authority; No Violation, Etc.

     The execution, delivery and performance by the Buyer of this Agreement has been duly authorized by all necessary limited liability company action. This Agreement and the other Basic Documents to which it is a party have been duly executed and delivered by the Buyer, and the execution, delivery and performance by the Buyer of this Agreement and the other Basic Documents to which it is a party does not and will not (i) conflict with or violate any provision of its certificate of formation or operating agreement; (ii) violate or result in a breach of any of the terms of, result in a modification of, or otherwise give any other contracting party the right to terminate, or constitute (or with notice or lapse of time or both would constitute) a default under, any contract or other agreement to which the Buyer is a party or by or to which the Buyer or any of its assets or properties may be bound or subject; (iii) violate any order, writ, judgment, injunction, award or decree of any Governmental Authority against, or binding upon, the Buyer; (iv) violate any statute, law or regulation of any jurisdiction; or (v) require the consent of any Person under any agreement or instrument to which the Buyer is a party.

      Section 3A.2 Investment; Experience.

     It is the present intention of the Buyer to acquire the Securities for investment for its own account, not as a nominee or agent, and not with the view to, or for resale in connection with, any distribution thereof. The Buyer and its members have significant experience in evaluating and investing in private placement transactions so that they are capable of evaluating the merits and risks of their investment in the Company, and have the capacity to protect their own interests. The Buyer represents that it and its members are “accredited investors” as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.

      Section 3A.3 Rule 144, etc.

     The Buyer acknowledges that the Securities must be held indefinitely unless subsequently registered under the Securities Act and any applicable state securities laws or unless exemptions from such registration are available. The Buyer is aware of the provisions of Rule 144 promulgated under the Securities Act which permit limited resale of shares purchased in a private placement subject to the satisfaction of certain conditions.

- 24 -

      Section 3A.4 Brokers or Finders.

     The Company has not, and will not, incur, directly or indirectly, as a result of any action taken by the Buyer, and liability for brokerage or finders’ fees in connection with this Agreement. The Buyer represents that it has not paid or agreed to pay any brokerage or finders’ fees in connection with this Agreement.

      Section 3A.5 Legends; Stop Transfer.

     Subject to the rights of the Buyer (and its permitted transferees) created under the Registration Rights Agreement, all certificates representing ownership of the Series A Preferred Shares and the Common Shares that may be purchased by the Buyer pursuant to the provisions of this Agreement shall bear the following legend:

“These securities have not been registered under the Securities Act of 1933, as amended. They may not be sold, offered for sale, pledged or hypothecated in the absence of an effective registration statement as to the securities under said Acts or an opinion of counsel satisfactory to the Company that such registration is not required.”

     In addition, the Company shall make a notation regarding the restrictions on transfer of the Series A Preferred Shares and the Common Shares in its books to the effect stated in this Section 3A.5.

      Section 3A.6 Enforceability.

     This Agreement is the legal, valid and binding obligation of the Buyer, enforceable against it in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally or the effect of general principles of equity.

      Section 3A.7 Governmental Approvals, etc.

     Except as set forth herein, no authorization, consent, approval, order, license or permit from, or filing, registration or qualification with, or exemption from any of the foregoing from, any Governmental Authority is or will be required to authorize or permit the execution, delivery and performance by the Buyer of the Basic Documents.

      Section 3A.8 Certain Trading Activities.

     During the 15 calendar days before the date of this Agreement, the Buyer has not engaged in, nor has the Buyer engaged any Person acting on its behalf to engage in, any trading of the Common Stock, including Short Sales of the Common Stock, and no open position or Short Sale relating to the Common Stock exists on the date hereof in the name or on behalf of the Buyer. For purposes of this Section, “Short Sales” means all kinds of direct and indirect stock pledges reflecting short positions, forward sale contracts, options, puts, calls, short sales, swaps (including on a total return basis), and sales and any other transactions having the effect of hedging any position in the Common Stock.

- 25 -

      Section 3A.9 Reliance on Exemptions . The Buyer understands that the Securities are being offered and sold to the Buyer in reliance upon specific exemptions from the registration requirements of the United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and the Buyer’s compliance with, certain of the representations, warranties, agreements and acknowledgments of the Buyer set forth herein to determine the availability of such exemptions and the eligibility of the Buyer and its members to acquire the Securities.

      Section 3A. 10 Information . The Buyer has been furnished with certain materials (including the SEC Reports) relating to the business, finances and operations of the Company that have been made publicly available by the Company, as well as materials relating to the offer and sale of the Securities. Notwithstanding the foregoing, the Buyer does not know, and has no basis for acknowledging, whether such materials are complete and accurate, or whether they comply with applicable Securities Laws in form and content, and is relying solely upon the reps and warranties of the Company set forth in this Agreement and the other Basic Documents with respect thereto. The Buyer has been afforded the opportunity to ask questions of the Company and has received responses from the Company and its advisors. The Buyer and its members acknowledge and understand that its investment in the Securities involves a significant degree of risk. Except for the representations and warranties set forth in this Article 3A or in the other Basic Documents, the Buyer has not made any representation or warranty, express or implied .

ARTICLE 4

COVENANTS OF THE COMPANY

     The Company hereby agrees that, so long as the Buyer (or any successive holder) owns Series A Preferred Shares or Common Shares, the Company shall:

      Section 4.1 Use of Proceeds. Use the proceeds from the sale of the Securities to provide general working capital for corporate purposes.

      Section 4.2 Reports and Statements. Deliver to the Buyer promptly upon (but in no case later than fifteen (15) days thereafter) any distribution to its security holders generally, to its Board of Directors or to the financial community of an annual report, quarterly report, proxy statement, registration statement or other similar reports or communications, a copy of each such document, and promptly upon filing by the Company with the SEC or the NASD, Inc., the National Market System, Inc. or any national securities exchange or other market system of any and all regular and other reports or applications, a copy of each such document, and a copy of such report or statement and copies of all press releases and other statements made available generally by the Company to the public concerning developments in the Company.

      Section 4.3 Financial Statements . Furnish to the Buyer promptly upon (but in no case later than fifteen (15) days thereafter) their becoming available, copies of all financial statements, reports, notices and proxy statements sent or made available generally by the

- 26 -

Company to its security holders, of all regular and periodic reports and all final registration statements and final prospectuses, if any, filed by the Company with any securities exchange or other self-regulatory organization, or with the Securities and Exchange Commission or any Governmental Authority. Concurrently with the delivery of the financial statements referred to in the preceding sentence, a certificate of a Responsible Officer of the Company stating that, to the best of such officer’s knowledge, the Company during such period has observed or performed all of its covenants and other agreements, and satisfied every condition, contained in this Agreement and the Basic Documents to be observed, performed or satisfied by it, and that such officer has obtained no knowledge of any default of any other Person except as specified in such certificate.

      Section 4.4 Payment of Obligations . Pay, discharge or otherwise satisfy at or before maturity or before they become delinquent (allowing for any grace period granted therein), as the case may be, all its obligations and liabilities of whatever nature, except when the amount or validity thereof is currently being contested in good faith by appropriate proceedings and reserves in conformity with GAAP with respect thereto have been provided on the books of the Company, including without limitation, all amounts owing under the Tax Settlement Agreement.

      Section 4.5 Conduct of Business and Maintenance of Existence. Continue to engage in business of the same type as now conducted by the Company with respect to the business currently conducted, preserve, renew and keep in full force and effect its corporate existence and take all reasonable action to maintain all rights, privileges and franchises necessary or desirable in the normal conduct of its business; and comply with all material applicable Requirements of Law and all of its obligations (allowing for any grace period granted therein) except to the extent that the failure to comply therewith would not, individually or in the aggregate, have a Material Adverse Effect.

      Section 4.6 Maintenance of Insurance. Keep all property useful and necessary in its business in good working order and condition; maintain with financially sound and reputable insurance companies insurance (including, without limitation, directors and officers liability insurance covering each of the Company’s directors in an amount not less than $2,000,000 in the annual aggregate), with no gaps in coverage, in at least such amounts and against at least such risks as are usually insured against in the same general area by publicly-traded companies engaged in the same or a similar business; and furnish to the Buyer, upon written request, full information as to the insurance carried.

      Section 4.7 Inspection of Property; Books and Records; Discussions. Keep proper books of record and account in which full, true and correct entries in conformity with GAAP and all Requirements of Law shall be made of all dealings and transactions in relation to its business and activities; and permit the Buyer and its representatives to visit and inspect any of its properties and examine and make abstracts from any of its books and records at any reasonable time and as often as may reasonably be requested, and to discuss the business, operations, properties and financial and other condition of the Company with officers and employees of the Company and with its independent certified public accountants.

      Section 4.8 Notices. Give to the Buyer, no later than five (5) days after any fact, circumstance or event set forth below, notice of:

- 27 -

          (a) of any (i) default or event of default under any instrument or other agreement of the Company or (ii) litigation, investigation or proceeding which may exist at any time between the Company and any Governmental Authority, which in any such case, if adversely determined, would have a Material Adverse Effect;

          (b) of any litigation or proceeding affecting or involving the Company (i) in which the amount claimed is $75,000 (whether or not covered by insurance), or (ii) in which injunctive or similar relief is sought; and/or

          (c) of a fact, circumstance or trend that could reasonably be expected to have a Material Adverse Effect.

     Each notice pursuant to this subsection shall be accompanied by a statement of the chief executive officer or chief financial officer of the Company setting forth details of the occurrence, fact or circumstance referred to therein and stating what action the Company proposes to take with respect thereto. In addition, each notice pursuant to clause (c) of this subsection shall be accompanied by all pleadings and other papers filed in connection with such litigation or proceeding, to the extent permitted under applicable Securities Laws.

      Section 4.9 Payment of Taxes; Filing of Returns . The Company shall file all tax returns, statements, reports and forms when and as required to be filed by it, and will pay and discharge or caused to be paid or discharged, all taxes shown thereon to be due for the periods covered thereby, including interest and penalties, or will provide reserves for payment thereof to the extent required under GAAP. The charges, accruals and reserves on the books of the Company in respect of taxes and other governmental charges shall be adequate to cover the tax liabilities accruing with respect to or payable by the Company with respect to any tax return of the Company. The Company will take any and all actions required under, and will refrain from taking any action that would reasonably be expected to cause it to be in non-compliance with, the Tax Settlement Agreement on a timely basis so that the Tax Settlement Agreement remains in full force and effect and so that the Company incurs no additional liability thereunder.

      Section 4.10 2005 Stockholders’ Meeting. The Company, acting through its Board of Directors, shall, in accordance with the DGCL, the Exchange Act and any other applicable law (including Securities Laws):

          (a) duly call, give notice of, and within 150 days of May 31, 2005 (allowing for any additional days that may be required to respond to any comments of the SEC, if the Company acts in a timely manner with respect thereto), convene and hold the 2005 Stockholders’ Meeting in accordance with the Exchange Act, DGCL and the Company’s Certificate of Incorporation and Bylaws for the purpose of considering and taking action to amend the Company’s Certificate of Incorporation to remove the cumulative voting and classified board features currently in place.

          (b) prepare and file with the SEC a preliminary proxy statement relating to the 2005 Stockholders’ Meeting and use its best efforts to obtain and furnish the information required to be included by the SEC in the definitive form of proxy statement and to respond promptly to any comments made by the SEC with respect to the preliminary proxy statement and cause a

-28-

definitive proxy statement, including any amendment or supplement thereto, to be mailed to its stockholders;

          (c) include in the definitive proxy statement the recommendation of the Board of Directors that stockholders of the Company vote in favor of the amendments to the Certificate of Incorporation and Bylaws described in subsection (a) above;

          (d) use its best efforts to solicit from holders of its outstanding shares of Common Stock, proxies in favor of the aforementioned amendments to the Certificate of Incorporation and Bylaws and to take all other action reasonably necessary or advisable to secure any vote or consent of stockholders required by DGCL to approve such amendments; and

          (e) within fourteen (14) days of receipt by the Company of completed Directors’ and Officers’ Questionnaires of the Series A Directors (as defined in the Certificate of Designation), file with the SEC the information statement required by and in accordance with Rule 14f-1 under the Exchange Act, and within seven (7) days of such filing, deliver such information statement to the Company’s stockholders as required by and in accordance with Rule 14f-1 under the Exchange Act.

Section 4.11 Preemptive Rights.

     (a) If, after the Closing Date but prior to the conversion of the Series A Preferred Shares into Common Shares, the Company shall propose to issue or sell New Securities or enters into any contract, commitment, agreement or understanding relating to the issuance or sale of any New Securities, the Buyer shall have the right to purchase that number of New Securities at the same price and on the same terms proposed to be issued or sold by the Company so that the Buyer would, after the issuance and sale of all such New Securities, hold the same proportionate interest (the “Proportionate Percentage”) of the then outstanding shares of Common Stock as was held by the Buyer immediately prior to such issuance and sale (based on the number of shares of Common Stock to be received upon conversion of the Series A Preferred Shares).

     (b) The Company shall give the Buyer written notice of its intention to issue and sell New Securities, describing the type of New Securities, the price and the general terms and conditions upon which the Company proposes to issue the same. The Buyer shall have fifteen (15) days (the “Offer Period”) from the giving of such notice to agree to purchase all or any part of its Proportionate Percentage of New Securities for the price and upon the terms and conditions specified in the notice by giving written notice to the Company and stating therein the quantity of New Securities to be purchased.

     (c) If the Buyer fails to provide written notice to the effect that the Buyer agrees to exercise such right within the Offer Period, the Company shall have 125 days thereafter to sell the New Securities in respect of which the Buyer’s rights were not exercised, at a price and upon the terms and conditions no more favorable to the buyers thereof than specified in the Company’s notice to the Buyer pursuant to this Section 4.11. If the Company has not sold the New Securities within such 125-day period, the Company shall not thereafter issue or sell any New

-29-

Securities, except by giving the Buyer the right to purchase its Proportionate Percentage in the manner provided in this Section 4.11.

Section 4.12 Repurchase Rights.

     (a)  Change of Control . If, at any time, there shall be a Change of Control of the Company, the Buyer shall have the right (the “Repurchase Right”), at its sole option, upon ten (10) days’ prior written notice to the Company (the “Redemption Notice”), to require the Company to purchase for cash from the Buyer, all but not less than all, of the Series A Preferred Shares at a price equal to 100% of the Liquidation Preference for such shares (subject to adjustment in accordance with adjustments to the Series A Preferred Shares conversion price provided for in the Certificate of Designation), plus any accrued and unpaid dividends to the date of repurchase. The Company shall deliver written notice to the Buyer promptly upon occurrence of an event of a Change of Control.

     (b)  Tax Settlement Agreement . If, at any time, the Company shall be notified by the IRS (which notice shall be transmitted to the Buyer within three (3) days upon receipt of such notice by the Company) that, for whatever reason and whether or not the Company has breached the provisions of Section 3.9 or Section 4.9 of this Agreement, the Tax Settlement Agreement is no longer in valid and in full force and effect, or that the Company has violated the terms of the Tax Settlement Agreement with the result (after the expiration of any grace or cure period permitted by the IRS), in either case, that the Company has additional liabilities or must make additional payments to the IRS beyond the settlement payment made to the IRS in 2003 pursuant to the Tax Settlement Agreement, then the Buyer shall have the right, at its sole option, upon ten (10) days’ prior written notice to the Company, to require the Company to purchase for cash from the Buyer, all but not less than all, of the Series A Preferred Shares at a price equal to 100% of the Liquidation Preference for such shares (subject to adjustment in accordance with adjustments to the Series A Preferred Shares conversion price provided for in the Certificate of Designation), plus any accrued and unpaid dividends to the date of repurchase.

      Section 4.13. Reservation of Common Shares. From and after the Closing, the Company shall at all times reserve for issuance the number of duly authorized Common Shares issuable upon conversion of the Series A Preferred Shares, and, from and after the 2005 Stockholders’ Meeting (assuming the Company’s stockholders approve the necessary increase in the number of authorized shares of Common Stock), the Company shall at all times reserve for issuance the number of duly authorized Common Shares issuable in connection with any of the Put Option Closings, on a fully-diluted basis, in accordance with the terms of this Agreement and the Certificate of Designation.

      Section 4.14 Transactions with Affiliates. Not enter into any transaction, including, without limitation, any purchase, sale, lease or exchange or property or the rendering of any service with any Affiliate (other than with any consolidated subsidiary), except for the transactions expressly permitted by this Agreement.

      Section 4.15 Subsidiaries. Not dissolve any Significant Subsidiaries.

-30-

      Section 4.16 Further Assurances . The Company shall execute and deliver all further instruments and documents and take all further action that may be necessary, or that the Buyer may reasonably request, in order to carry out the provisions of this Agreement or the other Basic Documents, including any assignments of the Buyer’s interest in the Securities or its rights under or for the benefit of the Basic Documents.

ARTICLE 5

COVENANTS OF THE BUYER

      Section 5.1 Put Option Shares. Subject to the terms and conditions set forth below, the Buyer hereby agrees as follows:

(a)

First Put Option Shares . The Buyer hereby agrees to grant to the Company the right to require the Buyer to purchase from the Company 500,000 First Put Option Shares at a price of $2.00 per share on a date which is no later than the sixtieth (60 th ) day after the date on which the Company’s Annual Report on Form 10-K is required to be filed with the SEC under the Exchange Act (not giving effect to Form 12b-25) (the “Filing Date”) with respect to FY 2006. No later than the thirtieth (30 th ) day after the Filing Date, the Buyer shall have received in writing from the Company: (i) a notice (the “Election Notice”) from the Company indicating whether the Company will exercise the First Put Option and (ii) a certificate of a Responsible Officer (the “Compliance Certificate”) certifying that all of the conditions set forth in clauses (i) through (vi) below have been fulfilled (with such confirming information as the Buyer may reasonably request, to the extent the provision by the Company of such information is not already required by this Agreement). If so the Company so elects to exercise the First Put Option, the Buyer shall purchase the First Put Option Shares in accordance with the terms of this Section 5.1(a) and on a date which is no later than sixty (60) days after the Filing Date; provided, however, that there shall be an extension of time beyond such closing date by the number of days that the Company was late in delivering the Election Notice or the Compliance Certificate, and further provided however, that if the Election Notice or Compliance Certificate is not received by the sixtieth (60 th ) day after the Filing Date, the First Put Option shall automatically become null and void and no longer exercisable thereafter, unless the Buyer decides to the contrary in its sole discretion and gives such written notice to the Company. The Buyer’s obligation to purchase the First Put Option Shares is also subject to the following conditions:

(i) the Company reports total operating revenues greater than $32.25 million for FY 2006 or $8.0625 million in total operating revenues for the fourth quarter of FY 2006, as set forth in its Annual Report on Form 10-K for FY 2006; provided, however , that the foregoing revenue milestones shall not be applicable in the event that the Buyer fails to purchase, upon the exercise by the Company of the Variable Price Put Option, Variable Price Put Option Shares in accordance with, and subject to the terms and conditions set forth in, Section 5.1(c) of this Agreement, but further

-31-

provided, however , that all of the other conditions to the First Put Option Closing set forth in clauses (ii) through (vi) below shall nevertheless remain applicable in such event; and

(ii) the Tax Settlement Agreement remains in full force and effect and the Company has incurred no additional liability thereunder; and

(iii) there has been no Change of Control since the Closing Date; and

(iv) there is not then (nor has there been, unless cured) a violation or breach of any of the representations, warranties, covenants and agreements of the Company under this Agreement or the other Basic Documents (as qualified therein as to materiality or knowledge, as the case may be); provided, however , that the Buyer shall not refuse to purchase the First Put Option Shares solely as a result of the non-fulfillment of the condition set forth in this clause (iv) if, but only if, Losses with respect to which the Buyer is otherwise entitled to indemnification under Article 8 have not exceeded $75,000 in the aggregate as of the date of exercise by the Company of the First Put Option; and

(v) (1) The Company or any Significant Subsidiary shall not have commenced any case, proceeding or other action (A) under any existing or future law of any jurisdiction, domestic of foreign, relating to bankruptcy, insolvency, reorganization or relief of debtors, seeking to have an order for relief entered with respect to it, or seeking to adjudicate it a bankrupt or insolvent, or seeking reorganization, arrangement, adjustment, winding-up, liquidation, dissolution, composition or other relief with respect to it or its debts, or (B) seeking appointment or a receiver, trustee, custodian or other similar official for it or for all or any substantial part of its assets, or the Company shall make a general assignment for the benefit of its creditors; or (2) there shall be commenced against the Company or any Significant Subsidiary any case, proceeding or other action of a nature referred to in clause (1) above which (A) results in the entry of an order for relief or any such adjudication or appointment or (B) remains undismissed, undischarged or unbonded for a period of sixty (60) days; or (3) there shall not have been commenced against the Company or any Significant Subsidiary any case, proceeding or other action seeking issuance of a warrant of attachment, execution, distraint or similar process against all or any substantial part of its assets, which results in the entry of an order for any such relief which shall not have been vacated, discharged, or stayed or bonded pending appeal within ten (10) days from the entry thereof; or (4) the Company or any Significant Subsidiary shall not have taken any action in furtherance of, or indicating its consent to, approval of, or acquiescence in, any of the acts set forth in clause (1), (2) or (3) above; or (5) the Company and each Significant Subsidiary shall be able to pay, and has not

-32-

admitted in writing that it is unable to pay, its debts as they generally become due; and

(vi) One or more judgments or decrees shall be entered against the Company or any Significant Subsidiary involving in the aggregate a liability (not paid or fully covered by insurance) of $75,000 or more and all such judgments or decrees shall not have been vacated, discharged, or stayed or bonded pending appeal within sixty (60) days from the entry thereof.

(b)

Second Put Option Shares . The Buyer hereby agrees to grant to the Company the right to require the Buyer to purchase from the Company 500,000 Second Put Option Shares at a price of $2.16 per share on a date which is no later than the sixtieth (60 th ) day after the date on which the Company’s Annual Report on Form 10-K is required to be filed with the SEC under the Exchange Act (not giving effect to Form 12b-25) (the “Filing Date”) with respect to FY 2007. No later than the thirtieth (30 th ) day after the Filing Date, the Buyer shall have received in writing from the Company: (i) a notice (the “Election Notice”) from the Company indicating whether the Company will exercise the Second Put Option and (ii) a certificate of a Responsible Officer (the “Compliance Certificate”) certifying that all of the conditions set forth in clauses (i) through (vi) below have been fulfilled (with such confirming information as the Buyer may reasonably request, to the extent the provision by the Company of such information is not already required by this Agreement). If so the Company so elects to exercise the Second Put Option, the Buyer shall purchase the Second Put Option Shares in accordance with the terms of this Section 5.1(a) and on a date which is no later than sixty (60) days after the Filing Date; provided, however, that there shall be an extension of time beyond such closing date by the number of days that the Company was late in delivering the Election Notice or the Compliance Certificate, and further provided however, that if the Election Notice or Compliance Certificate is not received by the sixtieth (60 th ) day after the Filing Date, the Second Put Option shall automatically become null and void and no longer exercisable thereafter, unless the Buyer decides to the contrary in its sole discretion and gives such written notice to the Company. The Buyer’s obligation to purchase the Second Put Option Shares is also subject to the following conditions:

(i) the Company reports total operating revenues greater than $39.75 million for FY 2007 or $9.9375 million in total operating revenues for the fourth quarter of FY 2007, as set forth in its Annual Report on Form 10-K for FY 2007; and

(ii) the Tax Settlement Agreement remains in full force and effect and the Company has incurred no additional liability thereunder; and

(iii) there has been no Change of Control; and

(iv) there is not then (nor has there been, unless cured) a violation or breach of any of the representations, warranties, covenants and agreements

-33-

of the Company under this Agreement or the other Basic Documents (as qualified therein as to materiality or knowledge, as the case may be); provided, however , that the Buyer shall not refuse to purchase the Second Put Option Shares solely as a result of the non-fulfillment of the condition set forth in this clause (iv) if, but only if, Losses with respect to which the Buyer is otherwise entitled to indemnification under Article 8 have not exceeded $75,000 in the aggregate as of the date of exercise by the Company of the Second Put Option; and

(v) (1) The Company or any Significant Subsidiary shall not have commenced any case, proceeding or other action (A) under any existing or future law of any jurisdiction, domestic of foreign, relating to bankruptcy, insolvency, reorganization or relief of debtors, seeking to have an order for relief entered with respect to it, or seeking to adjudicate it a bankrupt or insolvent, or seeking reorganization, arrangement, adjustment, winding-up, liquidation, dissolution, composition or other relief with respect to it or its debts, or (B) seeking appointment or a receiver, trustee, custodian or other similar official for it or for all or any substantial part of its assets, or the Company shall make a general assignment for the benefit of its creditors; or (2) there shall be commenced against the Company or any Significant Subsidiary any case, proceeding or other action of a nature referred to in clause (1) above which (A) results in the entry of an order for relief or any such adjudication or appointment or (B) remains undismissed, undischarged or unbonded for a period of sixty (60) days; or (3) there shall not have been commenced against the Company or any Significant Subsidiary any case, proceeding or other action seeking issuance of a warrant of attachment, execution, distraint or similar process against all or any substantial part of its assets, which results in the entry of an order for any such relief which shall not have been vacated, discharged, or stayed or bonded pending appeal within ten (10) days from the entry thereof; or (4) the Company or any Significant Subsidiary shall not have taken any action in furtherance of, or indicating its consent to, approval of, or acquiescence in, any of the acts set forth in clause (1), (2) or (3) above; or (5) the Company and each Significant Subsidiary shall be able to pay, and has not admitted in writing that it is unable to pay, its debts as they generally become due; and

(vi) One or more judgments or decrees shall be entered against the Company or any Significant Subsidiary involving in the aggregate a liability (not paid or fully covered by insurance) of $75,000 or more and all such judgments or decrees shall not have been vacated, discharged, or stayed or bonded pending appeal within sixty (60) days from the entry.

(c)

Variable Price Put Option Shares . The Buyer hereby agrees to grant to the Company the right to require the Buyer to purchase from the Company that number of Variable Price Put Option Shares as is determined below, on a date which is no later than the

-34-

sixtieth (60 ^th ) day after the date on which the Company’s Annual Report on Form 10-K is required to be filed with the SEC under the Exchange Act (not giving effect to Form 12b-25) (the “Filing Date”) with respect to FY 2006. No later than the thirtieth (30 ^th ) day after the Filing Date, the Buyer shall have received in writing from the Company: (i) a notice (the “Election Notice”) from the Company indicating whether the Company will exercise the Variable Price Put Option and (ii) a certificate of a Responsible Officer (the “Compliance Certificate”) certifying that all of the conditions set forth in clauses (i) through (vi) below have been fulfilled (with such confirming information as the Buyer may reasonably request, to the extent the provision by the Company of such information is not already required by this Agreement). If so the Company so elects to exercise the Variable Price Put Option, the Buyer shall purchase the Variable Price Put Option Shares in accordance with the terms of this Section 5.1(a) and on a date which is no later than sixty (60) days after the Filing Date; provided, however, that there shall be an extension of time beyond such closing date by the number of days that the Company was late in delivering the Election Notice or the Compliance Certificate, and further provided however, that if the Election Notice or Compliance Certificate is not received by the sixtieth (60 ^th ) day after the Filing Date, the Variable Put Option shall automatically become null and void and no longer exercisable thereafter, unless the Buyer decides to the contrary in its sole discretion and gives such written notice to the Company. The number of Variable Price Put Option Shares purchasable hereunder will be determined by dividing $800,000 by: (A) $0.85 per share if total operating revenue of the Company for the six-month period commencing on December 1, 2005 and ending on May 31, 2006 (the “Stub Period”) is at least $14,000,000; (B) $0.70 per share if total operating revenue of the Company during the Stub Period is at least $13,000,000 but less than $14,000,000; (C) $0.60 per share if total operating revenue of the Company during the Stub Period is at least $12,000,000 but less than $13,000,000; (D) $0.52 per share if total operating revenue of the Company during the Stub Period is at least $11,000,000 but less than $12,000,000; (E) $0.46 per share if total operating revenue of the Company during the Stub Period is at least $10,000,000 but less than $11,000,000; and (F) $0.41 per share if total operating revenue of the Company during the Stub Period is below $10,000,000. The Buyer’s obligation to purchase the Variable Price Put Option Shares is also subject to the following conditions:

(i) the Tax Settlement Agreement remains in full force and effect and the Company has incurred no additional liability thereunder; and

(ii) there has been no Change of Control since the Closing Date; and

(iii) there is not then (nor has there been, unless cured) a violation or breach of any of the representations, warranties, covenants and agreements of the Company under this Agreement or the other Basic Documents (as qualified therein as to materiality or knowledge, as the case may be); provided, however , that the Buyer shall not refuse to purchase the Variable Price Put Option Shares solely as a result of the non-fulfillment of the condition set forth in this clause (iii) if, but only if, Losses with respect to

-35-

which the Buyer is otherwise entitled to indemnification under Article 8 have not exceeded $75,000 in the aggregate as of the date of exercise by the Company of the Variable Price Put Option; and

(iv) (1) The Company or any Significant Subsidiary shall not have commenced any case, proceeding or other action (A) under any existing or future law of any jurisdiction, domestic of foreign, relating to bankruptcy, insolvency, reorganization or relief of debtors, seeking to have an order for relief entered with respect to it, or seeking to adjudicate it a bankrupt or insolvent, or seeking reorganization, arrangement, adjustment, winding-up, liquidation, dissolution, composition or other relief with respect to it or its debts, or (B) seeking appointment or a receiver, trustee, custodian or other similar official for it or for all or any substantial part of its assets, or the Company shall make a general assignment for the benefit of its creditors; or (2) there shall be commenced against the Company or any Significant Subsidiary any case, proceeding or other action of a nature referred to in clause (1) above which (A) results in the entry of an order for relief or any such adjudication or appointment or (B) remains undismissed, undischarged or unbonded for a period of sixty (60) days; or (3) there shall not have been commenced against the Company or any Significant Subsidiary any case, proceeding or other action seeking issuance of a warrant of attachment, execution, distraint or similar process against all or any substantial part of its assets, which results in the entry of an order for any such relief which shall not have been vacated, discharged, or stayed or bonded pending appeal within ten (10) days from the entry thereof; or (4) the Company or any Significant Subsidiary shall not have taken any action in furtherance of, or indicating its consent to, approval of, or acquiescence in, any of the acts set forth in clauses (1), (2) or (3) above; or (5) the Company and each Significant Subsidiary shall be able to pay, and has not admitted in writing that it is unable to pay, its debts as they generally become due; and

(v) One or more judgments or decrees shall be entered against the Company or any Significant Subsidiary involving in the aggregate a liability (not paid or fully covered by insurance) of $75,000 or more and all such judgments or decrees shall not have been vacated, discharged, or stayed or bonded pending appeal within sixty (60) days from the entry thereof.

(d) Adjustments . The purchase price per Put Option Share purchasable by the Buyer at any of the First Put Option Closing, the Second Put Option Closing or the Variable Price Put Option Closing on the terms and conditions set forth above (the “Put Option Purchase Price”) and the number of Put Option Shares are subject to adjustment from time to time upon the occurrence of the events set forth below:

          (i) In the event the Company shall at any time after the date hereof (i) declare a dividend on the Common Stock payable in Common Stock or other securities of

-36-

the Company, (ii) subdivide the outstanding Common Stock, (iii) combine the outstanding Common Stock into a smaller number of shares or (iv) issue any shares of its capital stock in a reclassification of the Common Stock (other than a change in par value, or from par value to no par value, or from no par value to par value), including, without limitation, any such reclassification in connection with a consolidation or merger in which the Company is the continuing corporation, the Put Option Purchase Price in effect at the time of the record date for such dividend or of the effective date of such subdivision, combination or reclassification and the number and kind of shares of capital stock and other securities issuable on such date shall be proportionately adjusted so that the Buyer shall be entitled to receive after such time, upon exercise of the Company’s right to issue and sell Put Option Shares to the Buyer under this Section 5.1 (the “Put Option Election”) and payment of the same aggregate amount as would have been payable before such time, the aggregate number and kind of shares of capital stock and other securities, which if the Put Option Election had been exercised in full immediately prior to such date and at a time when the Common Stock transfer books of the Company were open, the Buyer would have owned upon such exercise and been entitled to receive by virtue of such dividend, subdivision, combination or reclassification. Such adjustment shall be made successively whenever any event above shall occur.

          (ii) If, at any time, as a result of an adjustment made pursuant to paragraph (i) above, the Buyer thereafter shall become entitled to receive upon exercise any shares of capital stock of the Company other than Common Stock, the number of such other shares so receivable upon exercise of the Put Option Election shall be subject to adjustment from time to time in a manner and on terms as nearly equivalent as practicable to the provisions with respect to the shares contained in paragraph (a) above and the provisions of Section 4.2 of the Agreement shall apply on like terms to any such other shares.

      Section 5.2 Securities Laws. For so long as the Buyer holds any Securities, the Buyer will comply in all material respects with all applicable Securities Laws, and will use its best efforts to cause the Series A Directors to do the same.

-37-

ARTICLE 6

RESERVED

ARTICLE 7

RESERVED

ARTICLE 8

INDEMNIFICATION

     Each of the Company and the Buyer agree (each, in such case, an “Indemnifier”) to indemnify and hold harmless each other and their respective managers, members, directors, employees, representatives, agents and Affiliates (each, in such case, an “Indemnified Person”) from and against any and all claims, liabilities, judgments, actions, expenses, losses and damages (including any attorneys’ or accountants’ fees and expenses) (collectively, “Losses”) in any way related to, resulting from or arising out of any breach, violation or non-compliance of or with such Indemnifier’s representations, warranties, covenants and agreements set forth in this Agreement or any of the Basic Documents; provided, however, that any Indemnifier shall not be responsible for any Losses to the extent that it is finally judicially determined that they result primarily from actions taken or omitted to be taken by the Indemnified Person due to the Indemnified Person’s gross negligence or willful misconduct.

     The Indemnifier shall assume the defense of any claim or proceeding in respect of which indemnification is required hereunder, including the employment of counsel reasonably satisfactory to the Indemnified Person and the payment of all expenses. The Indemnified Person shall have the right to employ separate counsel selected by it with the reasonable approval of the Indemnifier in any such action or proceeding and to participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (a) the Indemnifier has agreed to pay such fees and expenses, (b) the Indemnifier shall have failed promptly to assume the defense of such action or proceeding and employ counsel reasonably satisfactory to the Indemnified Person in any such action or proceeding or (c) the named parties to any such action or proceeding (including any impleaded parties) include both an Indemnified Person and the Indemnifier, and such Indemnified Person shall have been advised by counsel that there may be one or more legal defenses available to such Indemnified Person that are different from or additional to, and potentially in conflict with, those available to the Indemnifier (in which case, if such Indemnified Person notifies the Indemnifier in writing that it elects to employ separate counsel at the expense of the Indemnifier, the Indemnifier shall not have the right to assume the defense of such action or proceeding on behalf of such Indemnified Person).

     The Indemnifier shall not, in connection with any one such action or proceeding or separate but substantially similar or related actions or proceedings arising out of the same general allegations or circumstances, be liable for the fees and expenses of more than one separate firm of attorneys (together with appropriate local counsel) at the time for the Indemnified Person and such other Indemnified Persons. The Indemnifier shall not be liable for any settlement of any such

-38-

action or proceeding effected without its consent, which consent shall not be unreasonably withheld, but if settled with its written consent or if there is a final and nonappealable judgment in such action or proceeding, the Indemnifier, subject to the proviso in the first paragraph of this Article 8, agrees to indemnify and hold harmless the Indemnified Person from and against any loss or liability (to the extent stated above) by reason of such settlement or judgment.

     If the indemnification provided for in this Article 8 is unavailable to an Indemnified Person under the first paragraph of this Article 8 (for any reason other than an Indemnified Person’s gross negligence or willful misconduct) in respect of any losses, claims, damages or liabilities referred to therein, then the Indemnifier, in lieu of indemnifying such Indemnified Person, and the Indemnified Person each shall contribute to the amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities: (i) in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and the Buyer, on the other hand, in connection with the matters covered by this Agreement; or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) but also the relative fault of the Company on the one hand, and the Buyer, on the other, as well as any other relevant equitable considerations. The amount paid or payable by a party as a result of the losses, claims, damages and liabilities referred to above shall be deemed to include any legal or other fees or expenses incurred in defending any action or claim. The Company and the Buyer agree that it would not be just and equitable if contribution pursuant to this paragraph were determined by pro rata allocation or by any other method which does not take into account the equitable considerations referred to in this paragraph. Notwithstanding the provisions of this Article 8, the Buyer shall not be required to contribute any amount in excess of the amount of fees actually received by the Buyer pursuant to this Agreement.

     The indemnity and contribution agreements contained in this Article 8 shall remain operative and in full force and effect regardless of any investigation made by or on behalf of any Indemnified Person.

     The respective representations and warranties made by the Company or the Buyer in this Agreement and the other Basic Documents shall survive the Closing until the later to occur of: (i) the third (3 ^rd ) anniversary of the Closing Date, or (ii) with respect to the representations and warranties contained in Sections 3.17, 3.20, 3.21 and 3.24 of this Agreement, the date on which the applicable statute of limitations expires; provided, however , that Sections 3.2 and 3.3 shall survive indefinitely.

     The Company (as Indemnifier) shall not be required to indemnify the Buyer or any other Indemnified Person with respect to any claim for indemnification of Losses unless and until the aggregate amount of all claims for Losses against the Company exceeds $75,000 (excluding from such $75,000 aggregate, any claim for Losses under $10,000 per claim), in which case, the Company shall be liable for the full amount of all such Losses (including the first $75,000 and not merely the excess over $75,000) without respect to either of such dollar limitations (for the purposes of determining whether the aggregate of such Losses exceeds $75,000 or if any individual Loss exceeds $10,000, any representation or warranty that is qualified by reference as to materiality shall be construed as not being so qualified); provided, however , that the foregoing

-39-

indemnification limitation shall not be applicable in the event of a binding and non-appealable finding that the Company committed fraud or malfeasance, and further provided, however, that the foregoing indemnification limitation shall not be applicable to Losses resulting from breaches or violations of Sections 3.2, 3.3 or 3.7 of this Agreement.

ARTICLE 9

MISCELLANEOUS

      Section 9.1 Fees and Expenses. The Company agrees to pay or reimburse the Buyer for paying any transfer, stamp, documentary or other similar taxes, assessments or charges levied by any governmental or revenue authority in respect of this Agreement or any of the other Basic Documents or any other document referred to herein or therein and all costs, expenses, taxes, assessments and other charges incurred in connection with any filing or registration contemplated by this Agreement or any other Basic Document or any document referred to herein or therein.

      Section 9.2 Certain Terms. As used herein, “Sections” refers to sections of this Agreement. As used herein, the expression “this Agreement” means the body of this Agreement; and the expressions “herein,” “hereof,” and “hereunder” and other words of similar import refer to this Agreement and not to any particular part or subdivision thereof. Whenever herein the singular number is used, the same shall include the plural where appropriate, and words of any gender shall include each other gender where appropriate.

      Section 9.3 Captions. The captions, headings and arrangements used in this Agreement are for convenience only and do not in any way affect, limit, amplify or modify the terms and provisions hereof.

      Section 9.4 Notices. Whenever this Agreement requires or permits any consent, approval, notice, request or demand from one party to another, such consent, approval, notice, request or demand must be in writing to be effective and shall be deemed to be delivered and received (i) if Personally delivered or if delivered by facsimile with telephonic confirmation, when actually received by the party to whom notice is sent, (ii) if delivered by mail within the United States (whether actually received or not), at the close of business on the third business day next following the day when placed in the federal mail, postage prepaid, certified or registered, addressed to the appropriate party or parties, at the address of such party set forth below (or at such other address as such party may designate by written notice to all other parties in accordance herewith) or (iii) if delivered by mail to any party located outside the United States, when received by the party to whom notice is sent:

If to the Buyer, to:

Woodcliff Healthcare Investment Partners LLC
35 ^th Floor
535 Madison Avenue
New York, New York 10022

-40-

Attention: Nicholas Lewin

Fax: 212-898-1161

and, with a copy to:

Attention: George Soterakis, Esq.
Holland & Knight LLP
195 Broadway
New York, New York 10007
Fax: 212-385-9010

If to the Company, to:

Comprehensive Care Corporation
204 South Hoover Boulevard, Suite 200
Tampa, Florida 33609

Attention: Chief Executive Officer
Fax: 813-288-4805

with a copy to:

Foley & Lardner LLP
100 N. Tampa Street, Suite 2700
Tampa, Florida 33602

Attention: Carolyn Long, Esq.
Fax: 813-221-4210

      Section 9.5 Governing Law. THE VALIDITY, CONSTRUCTION, ENFORCEMENT AND INTERPRETATION OF THIS AGREEMENT SHALL BE GOVERNED BY THE SUBSTANTIVE LAWS OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS MADE AND TO BE PERFORMED WHOLLY WITHIN SUCH STATE.

      Section 9.6 Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective heirs, representatives, successors, and permitted assigns, and any receiver, trustee in bankruptcy, or representative of the creditors of each such Person.

-41-

      Section 9.7 Invalid Provisions. If any provision of this Agreement is held to be illegal, invalid, or unenforceable under present or future laws effective during the term of this Agreement, such provision shall be fully severable; this Agreement shall be construed and enforced as if such illegal, invalid, or unenforceable provision had never comprised a part of this Agreement; and the remaining provisions of this Agreement shall remain in full force and effect and shall not be affected by the illegal, invalid, or unenforceable provision or by its severance from this Agreement. Furthermore, in lieu of each such illegal, invalid, or unenforceable provision there shall be added automatically as a part of this Agreement a provision as similar in terms to such illegal, invalid, or unenforceable provision as may be possible and be legal, valid, and enforceable.

      Section 9.8 Amendments. This Agreement may be amended, at any time and from time to time in whole or in part, or terminated, only by an instrument in writing, duly executed by all of the parties hereto.

      Section 9.9 Counterparts. This Agreement may be executed in any number of identical counterparts, each of which shall be deemed an original, and all of which shall constitute one and the same agreement.

      Section 9.10 Continuation of Rights. The failure or refusal of a party hereto to exercise any right granted in this Agreement shall not be deemed a waiver of the right to exercise future rights which may arise hereunder.

      Section 9.11 Entire Agreement. This Agreement, together with the other Basic Documents, contains the entire understanding of the parties hereto respecting the subject matter hereof and supersedes all prior agreements, discussions and understandings.

      Section 9.12 Consent to Jurisdiction and Service of Process. Any legal action, suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby may be instituted in any federal court in the State of New York, and each party waives any objection which such party may now or hereafter have to the laying of the venue of any such action, suit or proceeding, and irrevocably submits to the jurisdiction of any such court in any such action, suit or proceeding. Any and all service of process and any other notice in any such action, suit or proceeding shall be effective against any party if given by registered or certified mail, return receipt requested, or by any other means of mail which requires a signed receipt, postage prepaid, mailed to such party as herein provided. Nothing contained herein shall be deemed to affect the right of any party to serve process in any manner permitted by law or to commence legal proceedings or otherwise proceed against any other party in any jurisdiction other than the federal courts in New York.

-42-

     IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed on the date first above written.

EXHIBIT 10.2

           REGISTRATION RIGHTS AGREEMENT , dated as of June 14, 2005 (this “Agreement”), between COMPREHENSIVE CARE CORPORATION, a Delaware corporation (the “Corporation”), and WOODCLIFF HEALTHCARE INVESTMENT PARTNERS LLC, a Delaware limited liability company (the “Investor”).

          Pursuant to that certain Securities Purchase Agreement, dated as of the date hereof, between the Corporation and the Investor (the “Securities Purchase Agreement”), the Investor owns or has the right or obligation to purchase or otherwise acquire shares of the Common Stock (as hereinafter defined), or securities convertible into shares of Common Stock, of the Corporation. The Corporation and the Investor deem it to be in their respective best interests to set forth their rights in connection with public offerings and sales of the Common Stock and are entering into this Agreement as a condition to and in connection with the Investors entering into the Securities Purchase Agreement. All defined terms used in this Agreement, but not defined herein, shall have the meanings assigned to such terms in the Securities Purchase Agreement.

           NOW, THEREFORE, in consideration of the premises and mutual covenants and obligations hereinafter set forth, the Corporation and the Investors hereby agree as follows:

     Section 1. Definitions .

          As used in this Agreement, the following terms shall have the following meanings:

          “ Affiliate ” means, with respect to any Person, any (a) director, officer, limited or general partner, member or stockholder holding 5% or more of the outstanding capital stock or other equity interests of such Person, (b) any spouse, parent, sibling or descendant of such Person (or a spouse, parent, sibling or descendant of a Person specified in clause (a) above relating to such Person) and (c) other Person that, directly or indirectly, through one or more intermediaries, controls, or is controlled by, or is under common control with, such Person. The term “control” includes, without limitation, the possession, directly or indirectly, of the power to direct the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

          “ Board ” means the Board of Directors of the Corporation.

          “ Commission ” means the U.S. Securities and Exchange Commission.

          “ Common Stock ” means the common stock, $0.01 par value per share, of the Corporation.

          “ Demand Registration ” shall have the meaning set forth in Section 2(a).

          “ Exchange Act ” means the Securities Exchange Act of 1934 (or any successor statute), and the rules and regulations of the Commission promulgated thereunder, all as the same shall be in effect from time to time.

          “ Investor ” means Woodcliff Healthcare Investment Partners LLC, and includes any permitted transferee of, the Investor who or which agrees in writing to be treated as an Investor hereunder and to be bound by the terms and comply with all applicable provisions hereof.

          “ Investor Registrable Shares ” means shares of Common Stock issued or issuable to any Investor which constitute Restricted Shares.

          “ Person ” shall be construed in the broadest sense and means and includes a natural person, a partnership, a corporation, an association, a joint stock company, a limited liability company, a trust, a joint venture, an unincorporated organization and any other entity and any federal, state, municipal, foreign or other government, governmental department, commission, board, bureau, agency or instrumentality, or any private or public court or tribunal.

          “ Primary Shares ” means at any time authorized but unissued shares of Common Stock or shares of Common Stock held by the Corporation in its treasury.

          “ Registration Date ” means the date upon which the registration statement shall have been declared effective.

          “ Restricted Shares ” means shares of Common Stock issued or issuable at any time to the Investor, or issuable upon conversion, adjustment, exercise or exchange of and any other securities which by their terms are exercisable or exchangeable for or convertible into Common Stock which are held by the Investor (including, without limitation, the Series A Preferred Shares). As to any particular Restricted Shares, once issued, such Restricted Shares shall cease to be Restricted Shares when (i) they have been registered under the Securities Act, the registration statement in connection therewith has been declared effective by the Commission and they have been disposed of pursuant to such effective registration statement, (ii) they have been sold under circumstances in which all of the applicable conditions of Rule 144 (or any similar provisions then in force) under the Securities Act have been satisfied or are eligible for sale pursuant to Rule 144(k), (iii) they have been otherwise transferred, the Corporation has delivered a new certificate or other evidence of ownership for it not bearing the legend required pursuant to the Securities Purchase Agreement and they may be resold without subsequent registration under the Securities Act, or (iv) they shall have ceased to be outstanding.

          “ Rule 144 ” means Rule 144 promulgated under the Securities Act or any successor rule thereto.

          “ Securities Act ” means the Securities Act of 1933, as amended (or any successor statute), and the rules and regulations of the Commission thereunder, all as the same shall be in effect from time to time.

          “ Securities Purchase Agreement ” means the Securities Purchase Agreement, dated the date hereof, between the Corporation and the Investor, as the same may be modified, supplemented or amended from time to time.

          “ Selling Holder ” means a holder of Investor Registrable Securities who is selling Investor Registrable Securities pursuant to a registration statement under the Securities Act.

2

          “ Underwriter ” means a securities dealer who purchases any Investor Registrable Securities as principal and not part of such dealer’s market-making activities.

     Section 2. Required Registration .

          (a) At any time after the date which is the earlier to occur of: the ninetieth (90 ^th ) day after the Closing Date, if by such date, individuals designated by the Investor to be elected to the Board of Directors of the Corporation (in accordance with the Certificate of Designation (as defined in the Securities Purchase Agreement)) do not constitute a majority of the Board of Directors of the Corporation, or (ii) the first (1 ^st ) anniversary of the Closing Date, the holders of at least a majority of the Investor Registrable Shares then outstanding (determined on an as converted basis) may request in writing that the Corporation effect the registration under the Securities Act of all or part of their or its Investor Registrable Shares (a “Demand Registration”). Such request will specify the number of shares of Investor Registrable Shares proposed to be sold and will also specify the intended method of disposition thereof. Unless the holder or holders of a majority of the Investor Registrable Shares to be registered in such Demand Registration shall consent in writing, no other party, other than the Corporation shall be permitted to offer securities under any such Demand Registration. The Corporation shall promptly use its best efforts to effect the registration under the Securities Act of the Investor Registrable Shares as are specified in such request by preparing and filing a registration statement in compliance with the Securities Act.

          (b) Notwithstanding anything contained in this Section 2 to the contrary, the Corporation shall not be obligated to effect any registration under the Securities Act except in accordance with the following provisions:

     (i) The Corporation shall not be obligated to file and cause to become effective more than two registration statements initiated pursuant to Section 2(a) above; provided that, subject to Section 2(b)(v) below, a registration will not count as a Demand Registration pursuant to Section 2(a) until it has become effective.

     (ii) The Corporation may delay the filing or effectiveness of any registration statement for a period of up to 75 days after the date of a request for registration pursuant to Section 2(a) if at the time of such request: (X) the Corporation is engaged, or has fixed plans to engage within 45 days of the time of such request, in a firm commitment underwritten public offering of Primary Shares in which the holders of Investor Registrable Shares have been or will be permitted to include Investor Registrable Shares so requested to be registered pursuant to Section 3, or (Y) the Board in good faith reasonably determines that such registration and offering would either (A) require the disclosure of material information that the Corporation has a bona fide business purpose for preserving as confidential or (B) interfere with any material transaction involving the Corporation; provided , however , that the Corporation shall only be entitled to invoke its rights under this Section 2(b)(ii) one time during any consecutive 12-month period.

3

     (iii) With respect to any registration pursuant to this Section 2, the Corporation may include in such registration any Primary Shares; provided , however , that if the managing Underwriter advises the Corporation that the inclusion of all Investor Registrable Shares and Primary Shares proposed to be included in such registration would interfere with the successful marketing (including pricing) of the Investor Registrable Shares proposed to be included in such registration, then the number of Investor Registrable Shares and Primary Shares proposed to be included in such registration shall be included in the following order:

     (A) first, the Investor Registrable Shares (or, if necessary, such Investor Registrable Shares pro rata among the holders thereof based upon the number of Investor Registrable Shares requested to be registered by each such holder); and

     (B) second, the Primary Shares.

To the extent 10% or more of the Investor Registrable Shares so requested to be registered are excluded from the offering in accordance with this Section 2(b)(iii), the holders of such Investor Registrable Shares as a group shall have the right to one additional Demand Registration under this Section 2 with respect to such Investor Registrable Shares.

     (iv) If the registration requested pursuant to Section 2(a) above by holders of the Investor Registrable Shares is in the form of an underwritten offering, then the Corporation shall select the book-running managing Underwriter in connection with such offering and any additional investment bankers and managers to be used in connection with the offering; provided that such managing Underwriter and additional investment bankers and managers must be reasonably satisfactory to a majority of the Investors making such Demand Registration.

     (v) At any time before the registration statement covering a Demand Registration becomes effective, the holders of the Investor Registrable Shares initiating such request pursuant to Section 2(a) above may request the Corporation to withdraw or not to file the registration statement; provided , however , that the requested registration which has been rescinded shall count as a Demand Registration for purposes of Section 2(b)(i) unless (A) such request of withdrawal was caused by, or made in response to, a material adverse change or a similar event related to the business, properties, assets, condition, or operations of the Corporation not known (without imputing the knowledge of any other Person to such holders) by the holders initiating such request at the time their request was made, or (B) such Investors reimburse the Corporation for all expenses incurred in connection with such withdrawn request.

4

     Section 3. Piggyback Registration .

          (a) If the Corporation at any time proposes for any reason to register Primary Shares under the Securities Act (other than on Form S-4 or Form S-8 promulgated under the Securities Act (or any successor forms thereto)), it shall give written notice to the holders of Investor Registrable Shares of its intention to so register such Primary Shares as soon as practicable and in any event at least 30 days before the initial filing of the registration statement related thereto and, upon the request, delivered to the Corporation within 15 days after delivery of any such notice by the Corporation, of the holders of Investor Registrable Shares to include in such registration Investor Registrable Shares (which request shall specify the number of Investor Registrable Shares proposed to be included in such registration), the Corporation shall use its best efforts to cause all such Investor Registrable Shares to be included in such registration on the same terms and conditions as the securities otherwise being sold in such registration; provided , however , that if the managing Underwriter advises the Corporation that the inclusion of all Investor Registrable Shares requested to be included in such registration would interfere with the successful marketing (including pricing) of the Primary Shares proposed to be registered by the Corporation, then the number of Primary Shares and Registrable Shares proposed to be included in such registration shall be included in the following order:

     (A) first, the Primary Shares; and

     (B) second, the Investor Registrable Shares (or if necessary, such Investor Registrable Shares pro rata among the holders thereof based upon the number of Investor Registrable Shares requested to be registered by each such holder).

          (b) If at any time after giving written notice of its intention to register any Primary Shares and prior to the effective date of such registration, the Corporation shall determine for any reason not to register or to delay registration of such securities, the Corporation may, at its election, give written notice of such determination to the holders of Investor Registrable Shares who or which have requested that their Investor Registrable Shares be included in the registration effected pursuant to Section 3(a) and, thereupon, (i) in the case of a determination not to register, the Corporation shall be relieved of its obligations to register any Investor Registrable Shares in connection with such registration and (ii) in the case of a determination to delay such registration, the Corporation shall be permitted to delay registration of any Investor Registrable Shares requested to be included in such registration for the same period as the delay in registering such other securities.

     Section 4. Registrations on Form S-3 .

          Anything contained in Section 2 to the contrary notwithstanding, at such time as the Corporation shall have qualified for the use of Form S-3 promulgated under the Securities Act or any successor form thereto, the holders of Investor Registrable Shares shall have the right to request an unlimited number of registrations of Investor Registrable Shares on Form S-3 (which may, at such holders’ request, be shelf registrations pursuant to Rule 415 promulgated under the Securities Act) or its successor form, which request or requests shall (i) specify the number of

5

Investor Registrable Shares intended to be sold or disposed of and the holders thereof, (ii) state whether the intended method of disposition of such Investor Registrable Shares is an underwritten offering or a shelf registration and (iii) relate to Investor Registrable Shares having an estimated aggregate offering price of at least $500,000. A requested registration on Form S-3 (or its successor form) in compliance with this Section 4 shall not count as a registration statement initiated pursuant to Section 2(a) but shall otherwise be treated as a registration initiated pursuant to Section 2(b) (including Section 2(b)(iii)).

     Section 5. Preparation and Filing .

          If and whenever the Corporation is under an obligation pursuant to the provisions of this Agreement to effect the registration of any Investor Registrable Shares, the Corporation shall, as expeditiously as practicable:

          (a) use its best efforts to prepare and file with the Commission a registration statement on any form for which the Corporation then qualifies or which counsel for the Corporation shall deem appropriate and which form shall be available for the sale of the Investor Registrable Shares to be registered thereunder in accordance with the intended method of distribution thereof, and use its best efforts to cause such filed registration statement to become and remain effective until all of such Investor Registrable Shares have been disposed of;

          (b) furnish, at least five business days before filing a registration statement that registers such Investor Registrable Shares, to each Selling Holder, to each Underwriter, if any, of the Investor Registrable Securities covered by such registration statement and to one counsel selected by a majority of the holders of Investor Registrable Shares included in such registration (the “Investor Counsel”) copies of such registration statement as proposed to be filed, and thereafter furnish to such Selling Holder, Underwriter, if any, and Investor Counsel such number of copies of such registration statement, each amendment and supplement thereto (in each case including all exhibits thereto and documents incorporated by-reference therein), the prospectus included in such registration statement (including each preliminary prospectus), any amendment or supplement thereto and such other documents as such Selling Holder, Underwriter or Investor Counsel may reasonably request in order to facilitate the disposition of the Investor Registrable Shares owned by such Selling Holder (it being understood that such five-business day period need not apply to successive drafts of the same document proposed to be filed so long as such successive drafts are supplied to the Investors’ Counsel in advance of the proposed filing by a period of time that is customary and reasonable under the circumstances);

          (c) prepare and file with the Commission such amendments and supplements to such registration statement and the prospectus used in connection therewith as may be necessary to keep such registration statement effective until all of such Investor Registrable Shares have been disposed of and to comply with the provisions of the Securities Act with respect to the sale or other disposition of such Investor Registrable Shares;

          (d) notify in writing the Investor Counsel (i) of the receipt by the Corporation of any notification with respect to any comments by the Commission with respect to such registration statement or prospectus or any amendment or supplement thereto or any request by

6

the Commission for the amending or supplementing thereof or for additional information with respect thereto, (ii) of the receipt by the Corporation of any notification with respect to the issuance by the Commission of any stop order suspending the effectiveness of such registration statement or prospectus or any amendment or supplement thereto or the initiation or threatening of any proceeding for that purpose and (iii) of the receipt by the Corporation of any notification with respect to the suspension of the qualification of such Investor Registrable Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purposes;

          (e) use its best efforts to register or qualify such Investor Registrable Shares under such other securities or blue sky laws of such domestic and foreign jurisdictions as the Selling Holders reasonably request and do any and all other acts and things which may be reasonably necessary or advisable to enable the Selling Holders to consummate the disposition in such jurisdictions of the Investor Registrable Shares owned by the Selling Holders; provided , however , that the Corporation will not be required to qualify generally to do business, subject itself to general taxation or consent to general service of process in any jurisdiction where it would not otherwise be required to do so but for this paragraph (e);

          (f) furnish to the Selling Holders and the Underwriters, if any, such number of copies of a summary prospectus, if any, or other prospectus, including a preliminary prospectus, in conformity with the requirements of the Securities Act, and such other documents as such Selling Holders may reasonably request in order to facilitate the public sale or other disposition of such Registrable Shares;

          (g) without limiting subsection (e) above, use its best efforts to cause such Investors Registrable Shares to be registered with or approved by such other governmental agencies or authorities as may be necessary by virtue of the business and operations of the Corporation to enable the Selling Holders to consummate the disposition of such Investor Registrable Shares;

          (h) notify the Selling Holders, the Underwriters, if any, and the Investor Counsel on a timely basis at any time when a prospectus relating to such Investor Registrable Shares or any document related thereto includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing and, at the request of the Selling Holders prepare and furnish to such Selling Holders a reasonable number of copies of a supplement to or an amendment of such prospectus as may be necessary so that, as thereafter delivered to the offerees of such shares, such prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing;

          (i) make available upon reasonable notice and during normal business hours, for inspection by any Selling Holders of Investor Registrable Shares, any Underwriter participating in any disposition pursuant to such registration statement and any attorney, accountant or other agent retained by such Selling Holder or Underwriter (collectively, the “Inspectors”), all pertinent financial and other records, pertinent documents and properties of the Corporation (collectively, the “Records”), as shall be reasonably necessary to enable them to

7

exercise their due diligence responsibility, and cause the Corporation’s officers, directors and employees to supply all information (together with the Records, the “Information”) reasonably requested by any such Inspector in connection with such registration statement. Any of the Information which the Corporation determines in good faith to be confidential, and of which determination the Inspectors are so notified, shall not be disclosed by the Inspectors unless (i) the disclosure of such Information is necessary to avoid or correct a material misstatement or omission in the registration statement, (ii) the release of such Information is ordered pursuant to a subpoena or other order from a court or governmental agency or authority of competent jurisdiction, (iii) such Information has been made generally available to the public through no breach of the nondisclosure obligations of the Inspectors or their Affiliates or (iv) such disclosure is required to be made under applicable law. Each Selling Holder of such Investor Registrable Shares agrees that information obtained by it as a result of such inspections shall be deemed confidential and shall not be used by it as the basis for any market transactions in the securities of the Corporation or its Affiliates unless and until such is made generally available to the public. Each Selling Holder of such Investor Registrable Shares further agrees that it will, upon learning that disclosure of such Information is sought in a court of competent jurisdiction, give notice to the Corporation and allow the Corporation, at its expense, to undertake appropriate action to prevent disclosure of the Information deemed confidential;

          (j) use its best efforts to obtain from its independent certified public accountants “cold comfort” letters, addressed to each Selling Holder and to each Underwriter, in customary form and at customary times and covering matters of the type customarily covered by cold comfort letters;

          (k) use its best efforts to obtain from its counsel an opinion or opinions, addressed to each Selling Holder and to each Underwriter, in customary form and covering matters of the type customarily covered by opinions in registered public offerings;

          (l) provide a transfer agent and registrar (which may be the same entity and which may be the Corporation) for such Investor Registrable Shares;

          (m) promptly issue to any Underwriter to which the Selling Holders holding such Investor Registrable Shares may sell shares in such offering certificates evidencing such Investor Registrable Shares;

          (n) list such Investor Registrable Shares on any national securities exchange on which any shares of the Common Stock are then listed or, if the Common Stock is not listed on a national securities exchange, use its best efforts to qualify such Investor Registrable Shares for inclusion on NASDAQ or the American Stock Exchange;

          (o) otherwise use its best efforts to comply with all applicable rules and regulations of the Commission and make available to its securityholders, as soon as reasonably practicable, earnings statements covering a period of 12 months beginning within three months after the effective date of the subject registration statement, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act; and

8

          (p) otherwise use its best efforts to take all other steps necessary to effect the registration of such Investor Registrable Shares contemplated hereby.

          The Corporation may require each Selling Holder of Investor Registrable Shares to promptly furnish in writing to the Corporation such information regarding the distribution of the Investor Registrable Shares as the Corporation may from time to time reasonably request and such other information as may be legally required in connection with such registration.

          Each holder of the Investor Registrable Shares, upon receipt of any notice from the Corporation of any event of the kind described in Section 7(a) hereof, shall forthwith discontinue disposition of the Investor Registrable Shares pursuant to the registration statement covering such Investor Registrable Shares until such holder’s receipt of the copies of the supplemented or amended prospectus contemplated by Section 7(a) hereof, and, if so directed by the Corporation, such holder shall deliver to the Corporation all copies, other than permanent file copies then in such holder’s possession, of the prospectus covering such Investor Registrable Shares at the time of receipt of such notice.

     Section 6. Expenses .

          All expenses incurred by the Corporation and the Investor in complying with their obligations pursuant to this Agreement and in connection with the registration and disposition of Investor Registrable Shares, including, without limitation, all registration and filing fees (including all expenses incident to filing with the NASD), fees and expenses of complying with securities and blue sky laws, fees and expenses incurred in connection with the listing of the Investor Registrable Shares, printing expenses, fees and expenses of the Corporation’s counsel and accountants (including the expenses of any comfort letters or costs associated with the delivery by independent certified public accountants of a comfort letter or comfort letters requested pursuant to Section 5(j) hereof), fees and expenses of any special experts retained by the Corporation in connection with such registration and fees and expenses of the Investors’ Counsel shall be paid by the Corporation; provided , however , that all underwriting fees, discounts and selling commissions applicable to the Investor Registrable Shares shall be borne by the holders selling such Investor Registrable Shares, in proportion to the number of Investor Registrable Shares sold by each such holder.

     Section 7. Indemnification and Contribution .

          (a) In connection with any registration of any Investor Registrable Shares under the Securities Act pursuant to this Agreement, the Corporation shall indemnify and hold harmless each Selling Holder of Investor Registrable Shares, each of such holder’s officers, directors, employees, members, partners, advisors and agents and their respective Affiliates, and each other Person, if any, who controls any of the foregoing Persons within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act from and against any and all losses, claims, damages, liabilities, or actions joint or several (or actions in respect thereof), to which any of the foregoing persons may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or allegedly untrue statement of a material fact contained in

9

the registration statement under which such Investor Registrable Shares were registered under the Securities Act, any preliminary prospectus or final prospectus contained therein or otherwise filed with the Commission, any amendment or supplement thereto or any document incident to registration or qualification of any Investor Registrable Shares, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading or, with respect to any prospectus, necessary to make the statements therein in light of the circumstances under which they were made not misleading, or any violation by the Corporation of the Securities Act or state securities or blue sky laws applicable to the Corporation or relating to action or inaction required of the Corporation in connection with such registration or qualification under such state securities or blue sky laws; and shall reimburse such Persons for any legal or other expenses reasonably incurred by any of them in connection with investigating or defending any such loss, claim, damage, liability or action; provided , however , that the Corporation shall not be liable in any such case to the extent that any such losses, claims, damages, liabilities or actions (including any legal or other expenses incurred) arises out of or is based upon an untrue statement or allegedly untrue statement or omission or alleged omission made in said registration statement, preliminary prospectus, final prospectus, amendment, supplement or document incident to registration or qualification of any Registrable Shares in reliance upon and in conformity with written information furnished to the Corporation by such Selling Holder of Investor Registrable Shares specifically for use in the preparation thereof; provided further , however , that the foregoing indemnity agreement is subject to the condition that, insofar as it relates to any untrue statement, allegedly untrue statement, omission or alleged omission made in any preliminary prospectus but eliminated or remedied in the final prospectus, such indemnity agreement shall not inure to the benefit of any of such Persons if a copy of such final prospectus had been made available to such Persons and such final prospectus was not delivered to the purchaser of the Investor Registrable Shares with or prior to the written confirmation of the sale of such Registrable Shares. The Corporation also agrees to indemnify any underwriters of the Investor Registrable Shares, their officers and directors and each person who controls such underwriters.

          (b) In connection with any registration of Investor Registrable Shares under the Securities Act pursuant to this Agreement, each Selling Holder of Investor Registrable Shares shall severally and not jointly indemnify and hold harmless (in the same manner and to the same extent as set forth in Section 7(a)) the Corporation, each director of the Corporation, each officer of the Corporation who shall sign such registration statement, and each Person who controls any of the foregoing persons within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act with respect to any statement or omission from such registration statement, any preliminary prospectus or final prospectus contained therein or otherwise filed with the Commission, any amendment or supplement thereto or any document incident to registration or qualification of any Investor Registrable Shares, if such statement or omission was made in reliance upon and in conformity with written information furnished to the Corporation by such Selling Holder of Investor Registrable Shares specifically for use in connection with the preparation of such registration statement, preliminary prospectus, final prospectus, amendment, supplement or document; provided , however , that the maximum amount of liability in respect of such indemnification shall be limited, in the case of each Selling Holder of Investor Registrable Shares, to an amount equal to the net proceeds actually received by such holder from the sale of

10

Investor Registrable Shares effected pursuant to such registration. In case any action or proceeding shall be brought against the Corporation or its officers, directors or agents or any such controlling person, in respect of which indemnity may be sought against such Selling Holder, such Selling Holder shall have the rights and duties given to the Corporation, and the Corporation or its officers, directors or agents or such controlling person shall have the rights and duties given to such Selling Holder, by the preceding paragraph. Each Selling Holder also agrees to indemnify and hold harmless Underwriters of the Investor Registrable Securities, their officers and directors and each person who controls such Underwriters on substantially the same basis as that of the indemnification of the Corporation provided in this Section 7(b).

          (c) In case any action or proceeding (including any governmental investigation) shall be instituted involving any person in respect of which indemnity may be sought pursuant to Section 7(a) or 7(b), such person (an “Indemnified Party”) shall promptly notify the person against whom such indemnity may be sought (an “Indemnifying Party”) in writing and the Indemnifying Party shall assume the defense thereof, including the employment of counsel reasonably satisfactory to such Indemnified Party, and shall assume the payment of all fees and expenses, provided that the failure of any Indemnified Party to so notify an Indemnifying Party of any such action or proceeding shall not relieve the Indemnifying Party from any liability in respect of such action or proceeding that it may have to an Indemnified Party hereunder. In any such action or proceeding, any Indemnified Party shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party unless (i) the Indemnifying Party and the Indemnified Party shall have mutually agreed to the retention of such counsel or (ii) the named parties to any such proceeding (including any impleaded parties) include both the Indemnified Party and the Indemnifying Party and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them or (iii) the Indemnified Party shall have reasonably concluded that there may be one or more legal or equitable defenses available to such Indemnified Party which are additional to or conflict with those available to the Indemnifying Party, or that such claim or litigation involves or could have an effect upon matters beyond the scope of the indemnity agreement provided hereunder. It is understood that the Indemnifying Party shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees and expenses of more than one separate firm of attorneys (in addition to any local counsel) at any time for all such Indemnified Parties, and that all such fees and expenses shall be reimbursed as they are incurred. In the case of any such separate firm for the Indemnified Parties, such firm shall be designated in writing by the Indemnified Parties. The Indemnifying Party shall not be liable for any settlement of any proceeding effected without consent, but if settled with such consent, or if there be a final judgment for the plaintiff, the Indemnifying Party shall indemnify and hold harmless such Indemnified Parties from and against any loss or liability (to the extent stated above) by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an Indemnified party shall have requested an Indemnifying Party to reimburse the Indemnified Party for fees and expenses of counsel as contemplated by the third sentence of this paragraph, the Indemnifying Party agrees that it shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 30 business days after receipt by such Indemnifying Party of the aforesaid request and (ii) such Indemnifying Party shall not have reimbursed the Indemnified Party in accordance with such request prior to the date of

11

such settlement. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending or threatened action or proceeding in respect of with any indemnified party is or could have been a party and indemnity could have been sought hereunder by such Indemnified Party, unless such settlement includes an unconditional release of such Indemnified Party from all liability arising out of such action or proceeding.

          (d) If the indemnification provided for in this Section 7 is held by a court of competent jurisdiction to be unavailable to an Indemnified Party or insufficient with respect to any loss, claim, damage, liability or action referred to herein, then the Indemnifying Party, in lieu of indemnifying such Indemnified Party hereunder, shall contribute to the amounts paid or payable by such Indemnified Party as a result of such loss, claim, damage, liability or action (i) as between the Corporation and the Selling Holders on the one hand and the Underwriters on the other, in such proportion as is appropriate to reflect the relative benefits received by the Corporation and the Selling Holders on the one hand and the Underwriters on the other from the offering of the securities, or if such allocation is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits but also the relative fault of the Corporation and the Selling Holders on the one hand and of the Underwriters on the other in connection with the statements or omissions which resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations, and (ii) as between the Corporation on the one hand and each Selling Holder on the other, in such proportion as is appropriate to reflect the relative fault of the Corporation and of each Selling Holder in connection with such statements or omissions, as well as any other relevant equitable considerations. The relative benefits received by the Corporation and the Selling Holders on the one hand and the Underwriters on the other shall be deemed to be in the same proportion as the total proceeds from the offering (net of underwriting discounts and commissions but before deducting expenses) received by the Corporation and the Selling Holders bear to the total underwriting discounts and commissions received by the Underwriters, in each case as set forth in the table on the cover page of the prospectus. The relative fault of the Corporation and the Selling Holders on the one hand and of the Underwriters on the other shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Corporation and the Selling Holders or by the Underwriters. The relative fault of the Corporation on the one hand and of each Selling Holder on the other shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by such party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.

          The Corporation and the Selling Holders agree that it would not be just and equitable if contribution pursuant to this Section 7(d) were determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to in the immediately preceding paragraph. The amount paid or payable by an Indemnified Party as a result of the losses, claims, damages or liabilities referred to in the immediately preceding paragraph shall be deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by such Indemnified Party in connection with investigating or defending any

12

such action or claim. Notwithstanding the provisions of this Section 7(d), no Underwriter shall be required to contribute any amount in excess of the amount by which the total price at which the securities underwritten by it and distributed to the public were offered to the public exceeds the amount of any damages which such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission, and no Selling Holder shall be required to contribute any amount in excess of the amount by which the total price at which the Registrable Shares of such Selling Holder were offered to the public exceeds the amount of any damages which such Selling Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Selling Holder’s obligations to contribute pursuant to this Section 7(d) are several in proportion to the proceeds of the offering received by such Selling Holder bears to the total proceeds of the offering received by all the Selling Holders and not joint.

     Section 8. Participation; Information by Holder .

          (a) No Person may participate in any underwritten registration hereunder unless such Person (a) agrees to sell such Person’s securities on the basis provided in any underwriting arrangements approved by the Persons entitled hereunder to approve such arrangements and (b) completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and other documents reasonably required under the terms of such underwriting arrangements and these registration rights.

          (b) The Stockholders shall furnish to the Corporation such written information regarding the Investors and the distribution proposed by any Investors as the Corporation may reasonably request in writing and as shall be reasonably required in connection with any registration referred to in this Agreement.

     Section 9. Exchange Act Compliance .

          From the Registration Date or such earlier date as a registration statement filed by the Corporation pursuant to the Exchange Act relating to any class of the Corporation’s securities shall have become effective, the Corporation shall comply with all of the reporting requirements of the Exchange Act applicable to it and shall comply with all other public information reporting requirements of the Commission which are conditions to the availability of Rule 144. The Corporation shall cooperate with the Selling Holders in supplying such information as may be necessary for the Selling Holders to complete and file any information reporting forms presently or hereafter required by the Commission as a condition to the availability of Rule 144.

     Section 10. No Conflict of Rights; Future Rights .

          The Corporation represents and warrants that the registration rights granted hereby do not conflict with any other registration rights granted by the Corporation. The Corporation shall not, after the date hereof, grant any registration rights which conflict with or impair the rights granted under this Agreement.

13

     Section 11. Termination .

          This Agreement shall terminate and be of no further force or effect when there shall no longer be any Investor Registrable Shares outstanding.

     Section 12. Benefits of Agreement .

          Except as provided herein, this Agreement shall bind and inure to the benefit of the Corporation and Investors and, subject to Section 13, the respective successors and assigns of the Corporation and the Investor.

     Section 13. Assignment .

          The Investor may assign its rights hereunder to any Person to whom it transfers Common Stock or Series A Preferred Shares pursuant to and in accordance with the Securities Purchase Agreement; provided , however , that such transferee shall, as a condition to the effectiveness of such assignment, be required to execute a counterpart to this Agreement agreeing to be treated as a Stockholder whereupon such transferee shall have the benefits of, and shall be subject to the restrictions contained in, this Agreement as if such transferee was originally included in the definition of an Investor herein and had originally been a party hereto. The Corporation may not assign any rights hereunder without the consent of the Investor.

     Section 14. Entire Agreement .

          This Agreement, and the other writings referred to herein or delivered pursuant hereto, contain the entire agreement among the parties hereto with respect to the subject matter hereof and supersede all prior and contemporaneous arrangements or understandings with respect thereto.

     Section 15. Notices .

          All notices, requests, consents and other communications hereunder to any party shall be deemed to be sufficient if contained in a written instrument delivered in person or sent by telecopy, nationally-recognized overnight courier or first class registered or certified mail, return receipt requested, postage prepaid, addressed to such party at the address set forth below or such other address as may hereafter be designated in writing by such party to the other parties:

(i)

if to the Corporation, to:

Comprehensive Care Corporation
Suite 200
204 South Hoover Boulevard
Tampa, Florida 33609
Fax: (813) 288-4850
Attention: Chief Financial Officer

14

(ii)

if to the Investor, to:

Woodcliff Healthcare Investment Partners LLC
535 Madison Avenue, 35 ^th Floor
New York, New York 10022
Attention: Nicholas Lewin
Fax: 212-898-1161

or to such other address as the party to whom notice is to be given may have furnished to the other parties in writing in accordance herewith. All such notices, requests, consents and other communications shall be deemed to have been delivered (a) in the case of personal delivery or delivery by telecopy, on the date of such delivery, (b) in the case of dispatch by nationally-recognized overnight courier, on the next business day following such dispatch and (c) in the case of mailing, on the third business day after the posting thereof.

     Section 16. Modifications; Amendments; Waivers .

          The terms and provisions of this Agreement may not be modified or amended except pursuant to a writing signed by the Corporation and Investor or holders holding at least a majority of all Investor Registrable Shares. Any waiver of any provision of this Agreement requested by any party hereto must be granted in advance, in writing by the party granting such waiver; provided , however , that the holders of a majority of all then outstanding Investor Registrable Shares may grant a waiver on behalf of all holders holding as transferees of the Investor.

     Section 17. Delays or Omissions; Remedies .

          (a) No delay or omission to exercise any right, power or remedy accruing to the Investor, upon any breach or default of the Corporation under this Agreement shall impair any such right, power or remedy of the Investor nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of the Investor of any breach or default under this Agreement or any waiver on the part of the Investor of any provisions or conditions of this Agreement must be made in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to the Investor, shall be cumulative and not alternative.

          (b) In addition to any other remedies provided by law, it is acknowledged that it will be impossible to measure in money the damages that would be suffered if the parties hereto fail to comply with any of the obligations herein imposed on them and that in the event of any such failure, an aggrieved person will be irreparably damaged and will not have an adequate remedy at law. Any such aggrieved person shall, therefore, be entitled to injunctive relief, including specific performance, to enforce such obligations, and if any action should be brought in equity to enforce any of the provisions of this Agreement, none of the parties hereto shall, to the

15

fullest extent permitted by applicable law, raise the defense that there is an adequate remedy at law.

     Section 18. Counterparts; Facsimile Signatures .

          This Agreement may be executed in any number of original or facsimile counterparts, and each such counterpart hereof shall be deemed to be an original instrument, but all such counterparts together shall constitute but one agreement.

     Section 19. Headings .

          The headings of the various sections of this Agreement have been inserted for convenience of reference only and shall not be deemed to be a part of this Agreement.

     Section 20. Governing Law; Consent to Jurisdiction and Venue; Waiver of Jury Trial .

          This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without giving effect to any law or rule that would cause the laws of any jurisdiction other than the State of New York to be applied.

           ANY ACTION OR PROCEEDING AGAINST THE PARTIES RELATING IN ANY WAY TO THIS AGREEMENT MAY BE BROUGHT AND ENFORCED IN THE COURTS OF THE STATE OF NEW YORK OR THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, TO THE EXTENT SUBJECT MATTER JURISDICTION EXISTS THEREFOR, AND THE PARTIES IRREVOCABLY SUBMIT TO THE JURISDICTION OF BOTH SUCH COURTS IN RESPECT OF ANY SUCH ACTION OR PROCEEDING. EACH OF THE PARTIES IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION THAT THEY MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY SUCH ACTION OR PROCEEDING IN THE COURTS OF THE STATE OF NEW YORK LOCATED IN NEW YORK COUNTY OR THE SOUTHERN DISTRICT OF NEW YORK AND ANY CLAIM THAT ANY SUCH ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN ANY INCONVENIENT FORUM. ANY JUDGMENT MAY BE ENTERED IN ANY COURT HAVING JURISDICTION THEREOF.

           EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT.

     Section 21. Severability .

          It is the desire and intent of the parties that the provisions of this Agreement be enforced to the fullest extent permissible under the law and public policies applied in each jurisdiction in which enforcement is sought. Accordingly, in the event that any provision of this Agreement would be held in any jurisdiction to be invalid, prohibited or unenforceable for any reason, such provision, as to such jurisdiction, shall be ineffective, without invalidating the

16

remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction. Notwithstanding the foregoing, if such provision could be more narrowly drawn so as not be invalid, prohibited or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly drawn, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability of such provision in any other jurisdiction.

* * * *

17

           IN WITNESS WHEREOF , the parties hereto have executed this Registration Rights Agreement on the date first written above.

EXHIBIT 10.3

WAIVER OF CERTAIN EMPLOYMENT AGREEMENT ENTITLEMENTS

      THIS WAIVER OF CERTAIN EMPLOYMENT AGREEMENT ENTITLEMENTS (this “Agreement”) is dated as of June 14, 2005 (the “Effective Date”) by and between MARY JANE JOHNSON (hereinafter referred to as the “Executive”), and COMPREHENSIVE CARE CORPORATION, a Delaware corporation (hereinafter referred to as the “Corporation”).

RECITALS

      WHEREAS , the parties entered into that certain Employment Agreement dated effective February 7, 2003, as amended by that certain First Amendment dated as of the Effective Date (collectively, the “Employment Agreement”);

      WHEREAS , the Corporation has entered into a Securities Purchase Agreement, dated as of the Effective Date (the “Purchase Agreement”), pursuant to which the Corporation will issue to Woodcliff Healthcare Investment Partners, LLC (the “Investor”), 14,400 shares of the Corporation’s Series A Convertible Preferred Stock, $50.00 par value per share (“Series A Preferred Stock”) in exchange for $3,600,000.00 in cash, which represents a purchase price of $250.00 per share, as well as shares of the Corporation’s common stock, par value $0.01 per share, upon any exercise of the put options by the Corporation on the terms and conditions set forth in the Purchase Agreement (collectively, the “Private Offering”);

      WHEREAS , in conjunction with the Private Offering, the Corporation desires that Executive waive any entitlements the Executive may receive in the Event of a Change of Control from the Corporation and any entitlements the Executive may have to a Special Transaction Bonus as described hereinbelow; and

      WHEREAS , this waiver of certain of the Executive’s rights pursuant to her Employment Agreement is being delivered as a condition to the closing of the transactions contemplated by the Purchase Agreement in favor of the Investor and as partial consideration for the Investor’s purchase of the Series A Preferred Stock; and

      WHEREAS , Executive agrees to waive said entitlements.

      NOW, THEREFORE , in consideration of the mutual covenants hereinafter specified, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by each party, it is agreed as follows:

     1.  Recitals; Defined Terms . The recital clauses set forth hereinabove are true and correct and are incorporated herein by this reference. Except as expressly provided herein to the contrary, all capitalized terms utilized in this Agreement that are not defined in this Agreement shall have the meanings ascribed to such terms in the Employment Agreement.

     2.  Waiver of Change of Control Entitlements . The parties acknowledge that Article VI of the Employment Agreement states that, in the event of a Change of Control as described therein, (i) the Executive, in her sole discretion, may elect to terminate her employment at any time within one (1) year following the Change in Control and upon her election to terminate her employment, the Corporation is obligated to pay to Executive a Severance Benefit or (ii) in the event that Executive does not elect to terminate her employment within one year following a Change in Control and during such one year period or at any time thereafter during the unexpired term of this Agreement and (i) her employment is terminated by the Company for reasons other than cause, as defined herein, or (ii) though not terminated by the Company, Executive’s duties and responsibilities are materially curtailed or diminished from those prevailing immediately preceding the time of the Change in Control, and following such material

curtailment or diminution, Executive elects to terminate her employment irrespective of whether or not the term of this Agreement shall have expired, then the Company shall pay to the Executive a severance benefit equal to the greater of the Executive’s Base Salary for the unexpired portion of the term or an amount equal to two times the amount of Executive’s Base Salary [all of the remuneration and benefits described in clauses (i) and (ii) of this sentence hereinafter referred to as the (“Change of Control Entitlements”)]. In consideration of the Corporation’s amending Executive’s Employment Agreement in connection with the Private Offering, and other good and valuable consideration the receipt and sufficiency of which is hereby acknowledged by the Executive, the Executive hereby waives, releases, forfeits and relinquishes any and all right, claim, title and interest in and to the Change of Control Entitlements that may be triggered by the closing of the Private Offering, and agrees that the Corporation and its officers, directors, employees, stockholders, agents, successors and assigns shall have no obligation to make payment of or provision for the Change of Control Entitlements in such case.

     3.  Waiver of Special Transaction Bonus . The parties acknowledge that Article VIII of the Employment Agreement states that, upon the consummation of a Special Transaction, as described therein, the Corporation is obligated to pay to the Executive a Special Transaction Bonus equal to 1% of the Special Transaction Value in excess of $5 million [all of the remuneration and benefits described in this sentence hereinafter referred to as the (“Bonus Entitlements”)]. In consideration of the Corporation’s amending Executive’s Employment Agreement in connection with the Private Offering, and other good and valuable consideration the receipt and sufficiency of which is hereby acknowledged by the Executive, the Executive hereby waives, releases, forfeits and relinquishes any and all right, claim, title and interest in and to the Bonus Entitlements that may be triggered by the Private Offering, and agrees that the Corporation and its officers, directors, employees, stockholders, agents, successors and assigns shall have no obligation to make payment of or provision for the Bonus Entitlements in such case.

     4.  Binding; Specific Performance . This Agreement shall be binding upon, and inure to the benefit of, the parties hereto and the respective legal and personal representatives, heirs, successors and assigns of the parties hereto. The parties hereby declare that it is impossible to measure in money the damages that will accrue to a party hereto by reason of failure of the other party to perform any of their obligations under this Agreement. Therefore, if any party shall institute any action or proceeding to enforce the provisions hereof, the defendant or defendants against whom the action or proceeding is brought hereby waive the claim or defense therein that such a party has an adequate remedy at law, and such party shall not urge in any action or proceeding the claim or defense that a remedy at law exists.

     5.  Governing Laws . This Agreement shall be subject to, governed by, and construed in accordance with the laws of the State of Florida.

     6.  Waiver of Right to Trial by Jury . THE CORPORATION AND EXECUTIVE WAIVE THE RIGHT TO A TRIAL BY JURY IN ANY ACTION OR PROCEEDING BASED UPON, OR RELATED TO, THE SUBJECT MATTER OF THIS AGREEMENT. THIS WAIVER IS KNOWINGLY, INTENTIONALLY, AND VOLUNTARILY MADE BY EACH PARTY AND EACH PARTY EXPRESSLY ACKNOWLEDGES THAT NEITHER THE OTHER PARTY NOR ANY PERSON ACTING ON BEHALF OF THE OTHER PARTY HAS MADE ANY REPRESENTATIONS OF FACT TO INDUCE THIS WAIVER OF TRIAL BY JURY OR IN ANY WAY TO MODIFY OR NULLIFY ITS EFFECT. EACH PARTY ACKNOWLEDGES TO THE OTHER THAT IT HAS READ AND UNDERSTANDS THE MEANING AND EFFECT OF THIS WAIVER PROVISION.

     7.  Severability . If for any reason any provision of this Agreement is held invalid, such invalidity shall not affect any other provision of this Agreement not held invalid, and all such other provisions shall continue in full force and effect. If any provision of this Agreement shall be held invalid in part, such invalidities shall in no way affect the rest of such provision not held so invalid, and the rest of such provision, together with all other provisions of this Agreement, shall to the full extent consistent with law, continue in full force and effect.

2

     8.  Notices . Any notice or communication given pursuant hereto by any party shall be in writing and hand delivered or mailed by registered or certified mail, postage prepaid, to the party at the address set forth below or to such other address as a party may designate by written notice given to the other party in accordance with this provision.

     9.  Headings . The headings of the paragraphs of this Agreement are inserted for convenience of reference only and shall not constitute a part hereof.

     10.  Entire Agreement . This Agreement, including the other documents referred to herein which form a part hereof, contains the entire understanding of the parties hereto with respect to the subject matter contained herein and supersedes all prior agreements and understandings between the parties with respect to such subject matter.

     11.  Amendment . This Agreement may not be amended or modified except by instrument in writing signed by all of the parties.

     12.  Counterparts . This Agreement may be executed in any number of counterparts, by facsimile signature or otherwise, each of which shall be an original but all of which together shall constitute one and the same instrument.

[ Signature Page to Follow ]

3

      IN WITNESS WHEREOF , the parties hereto have executed this Agreement, effective the date first set forth above.

Acknowledged and Agreed

WOODCLIFF HEALTHCARE INVESTMENT PARTNERS, LLC

4

EXHIBIT 10.4

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT

      THIS AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (this “ Agreement ”) is made and entered into as of June 14, 2005, by and between COMPREHENSIVE CARE CORPORATION, a Delaware corporation (the “ Employer ”), and MARY JANE JOHNSON, an individual residing in the State of Florida (the “ Executive ”). Hereinafter, the Employer and the Executive are sometimes referred to individually as a “ Party ” and together as the “ Parties .”

W I T N E S S E T H:

      WHEREAS , the Parties have entered into an Employment Agreement, dated February 1, 2003, pursuant to which the Executive is employed as the President and Chief Executive Officer of the Employer (the “ Employment Agreement ”); and

      WHEREAS , the Parties desire to hereby amend the Employment Agreement in the manner specified herein.

      NOW THEREFORE , in consideration of the mutual promises contained herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties hereto agree as follows:

      1.  Definitions . All capitalized terms appearing in this Agreement and defined in the Employment Agreement shall have the definitions ascribed thereto in the Employment Agreement, unless otherwise specifically provided for herein.

      2.  Amendment to Article XI . Article XI of the Employment Agreement is hereby amended by deleting said section in its entirety and replacing it with the following:

     This Agreement shall have an initial term commencing February 1, 2003 and terminating on May 31, 2006. This Agreement shall be automatically renewed and extended on its same terms and conditions for up to two consecutive eighteen month periods unless either party gives written notice to the other at least six months prior to the initial termination date or renewal termination date, as the case may be, of its intention not to renew. In the event that the Company notifies Executive of its intent not to renew this Agreement, the Company agrees to pay to Executive, upon the expiration of this Agreement without renewal, a lump sum severance payment equal to two (2) years Base Salary. In addition, and commencing upon the expiration of this Agreement without renewal, the Company shall, at its expense, continue to provide Executive with her existing healthcare insurance coverage for 18 months or such shorter period that the Company may legally continue Executive’s healthcare insurance, in which case the Company shall reimburse Executive for the cost of comparable healthcare insurance coverage for Executive and her dependents for the period commencing the time of termination or discontinuance of Executive’s existing healthcare insurance and 18 months following Executive’s separation from the Company. However, no such entitlement will continue once Executive has coverage through another employer or has been added onto coverage available through her spouse’s employer if applicable.

1

      3.  Amendment to Article XII . Article XII of the Employment Agreement is hereby amended by deleting said section in its entirety and replacing it with the following:

     In the event that the Executive becomes totally disabled so that she is unable or prevented from substantially performing her usual duties as set forth in Article III hereunder after sixty (60) days following a triggering event, she will be considered terminated without cause as defined under Article XIII (C). Full salary and benefits will continue during the sixty (60) day period. The obligation of the Company to make the aforesaid payments shall be modified and reduced and the Company shall receive a credit for all disability insurance payments which Executive may receive or to which she may become entitled; provided, however, that the premiums for such disability insurance had been paid by the Company or had been reimbursed to Executive by the Company.

      4.  Amendments to Article XIII(C) . In Article XIII, Section (C) of the Employment Agreement, in the last sentence, the words “curtailment or diminution of the Executive’s duties and responsibilities” are hereby deleted and replaced with “or total disability as defined in Article XII herein.”

      5.  Amendment to Article XIII(D). Article XIII is hereby amended by adding the following language as Section (D) of said article:

     (D) In the event the Company materially curtails or diminishes Executive’s duties and responsibilities, Executive may elect to voluntarily terminate her employment after providing at least sixty (60) days notice of her intent to do so, regardless of whether the term of this Agreement shall have expired. Materiality, for purposes of this paragraph, shall include, but not be limited to, inserting an employee between Executive and the Board of Directors, or between Executive and her direct reports, or excluding Executive from the strategic planning process. In the event Executive’s employment is terminated under the terms of this paragraph, she will receive a severance benefit equal to the greater of the Executive’s Base Salary for the unexpired term of the Agreement, or an amount equal to two times the amount of Executive’s Base Salary, whichever is greater.

      6.  Miscellaneous . Except as specifically set forth in this Agreement, all of the terms and provisions of the Employment Agreement shall continue to remain in full force and effect. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, and all of which together shall constitute one document. This Agreement, together with the Employment Agreement, contains the final, complete, and exclusive expression of the Parties’ understanding and agreement concerning the matters contemplated herein and supersedes any prior or contemporaneous agreement of representation, oral or written, among them.

2

      IN WITNESS WHEREOF , the parties have executed this Amendment No. 1 to Employment Agreement on the day and year first written above.

3

EXHIBIT 10.5

WAIVER OF CERTAIN EMPLOYMENT AGREEMENT ENTITLEMENTS

      THIS WAIVER OF CERTAIN EMPLOYMENT AGREEMENT ENTITLEMENTS (this “Agreement”) is dated as of June 14, 2005 (the “Effective Date”) by and between ROBERT J. LANDIS (hereinafter referred to as the “Executive”), and COMPREHENSIVE CARE CORPORATION, a Delaware corporation (hereinafter referred to as the “Corporation”).

R E C I T A L S

      WHEREAS , the parties entered into that certain Employment Agreement dated effective February 7, 2003, as amended by that certain First Amendment dated as of the Effective Date (collectively, the “Employment Agreement”);

      WHEREAS , the Corporation has entered into a Securities Purchase Agreement, dated as of the Effective Date (the “Purchase Agreement”), pursuant to which the Corporation will issue to Woodcliff Healthcare Investment Partners, LLC (the “Investor”), 14,400 shares of the Corporation’s Series A Convertible Preferred Stock, $50.00 par value per share (“Series A Preferred Stock”) in exchange for $3,600,000.00 in cash, which represents a purchase price of $250.00 per share, as well as shares of the Corporation’s common stock, par value $0.01 per share, upon any exercise of the put options by the Corporation on the terms and conditions set forth in the Purchase Agreement (collectively, the “Private Offering”);

      WHEREAS , in conjunction with the Private Offering, the Corporation desires that Executive waive any entitlements the Executive may receive in the Event of a Change of Control from the Corporation and any entitlements the Executive may have to a Special Transaction Bonus as described hereinbelow; and

      WHEREAS , this waiver of certain of the Executive’s rights pursuant to his Employment Agreement is being delivered as a condition to the closing of the transactions contemplated by the Purchase Agreement in favor of the Investor and as partial consideration for the Investor’s purchase of the Series A Preferred Stock; and

      WHEREAS , Executive agrees to waive said entitlements.

      NOW, THEREFORE , in consideration of the mutual covenants hereinafter specified, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by each party, it is agreed as follows:

      1.  Recitals; Defined Terms . The recital clauses set forth hereinabove are true and correct and are incorporated herein by this reference. Except as expressly provided herein to the contrary, all capitalized terms utilized in this Agreement that are not defined in this Agreement shall have the meanings ascribed to such terms in the Employment Agreement.

      2.  Waiver of Change of Control Entitlements . The parties acknowledge that Article VI of the Employment Agreement states that, in the event of a Change of Control as described therein, (i) the Executive, in his sole discretion, may elect to terminate his employment at any time within one (1) year following the Change in Control and upon his election to terminate his employment, the Corporation is obligated to pay to Executive a Severance Benefit or (ii) in the event that Executive does not elect to terminate his employment within one year following a Change in Control and during such one year period or at any time thereafter during the unexpired term of this Agreement and (i) his employment is terminated by the Company for reasons other than cause, as defined herein, or (ii) though not terminated by the Company, Executive’s duties and responsibilities are materially curtailed or diminished from those prevailing immediately preceding the time of the Change in Control, and following such material

curtailment or diminution, Executive elects to terminate his employment irrespective of whether or not the term of this Agreement shall have expired, then the Company shall pay to the Executive a severance benefit equal to the greater of the Executive’s Base Salary for the unexpired portion of the term or an amount equal to two times the amount of Executive’s Base Salary [all of the remuneration and benefits described in clauses (i) and (ii) of this sentence hereinafter referred to as the (“Change of Control Entitlements”)]. In consideration of the Corporation’s amending Executive’s Employment Agreement in connection with the Private Offering, and other good and valuable consideration the receipt and sufficiency of which is hereby acknowledged by the Executive, the Executive hereby waives, releases, forfeits and relinquishes any and all right, claim, title and interest in and to the Change of Control Entitlements, and agrees that the Corporation and its officers, directors, employees, stockholders, agents, successors and assigns shall have no obligation to make payment of or provision for the Change of Control Entitlements in such case.

      3.  Waiver of Special Transaction Bonus . The parties acknowledge that Article VIII of the Employment Agreement states that, upon the consummation of a Special Transaction, as described therein, the Corporation is obligated to pay to the Executive a Special Transaction Bonus equal to 1% of the Special Transaction Value in excess of $5 million [all of the remuneration and benefits described in this sentence hereinafter referred to as the (“Bonus Entitlements”)]. In consideration of the Corporation’s amending Executive’s Employment Agreement in connection with the Private Offering, and other good and valuable consideration the receipt and sufficiency of which is hereby acknowledged by the Executive, the Executive hereby waives, releases, forfeits and relinquishes any and all right, claim, title and interest in and to the Bonus Entitlements, and agrees that the Corporation and its officers, directors, employees, stockholders, agents, successors and assigns shall have no obligation to make payment of or provision for the Bonus Entitlements in such case.

      4.  Term . The parties acknowledge and agree that Executive’s waiver of rights to the Change of Control Entitlements and Bonus Entitlements shall only be effective through November 30, 2007 (which date is the expiration date of the first renewal term under the Employment Agreement). If Executive’s Employment Agreement is extended for a second renewal, Executive’s waiver of the above rights shall no longer be effective.

      5.  Binding; Specific Performance . This Agreement shall be binding upon, and inure to the benefit of, the parties hereto and the respective legal and personal representatives, heirs, successors and assigns of the parties hereto. The parties hereby declare that it is impossible to measure in money the damages that will accrue to a party hereto by reason of failure of the other party to perform any of their obligations under this Agreement. Therefore, if any party shall institute any action or proceeding to enforce the provisions hereof, the defendant or defendants against whom the action or proceeding is brought hereby waive the claim or defense therein that such a party has an adequate remedy at law, and such party shall not urge in any action or proceeding the claim or defense that a remedy at law exists.

      6.  Governing Laws . This Agreement shall be subject to, governed by, and construed in accordance with the laws of the State of Florida.

      7. Waiver of Right to Trial by Jury . THE CORPORATION AND EXECUTIVE WAIVE THE RIGHT TO A TRIAL BY JURY IN ANY ACTION OR PROCEEDING BASED UPON, OR RELATED TO, THE SUBJECT MATTER OF THIS AGREEMENT. THIS WAIVER IS KNOWINGLY, INTENTIONALLY, AND VOLUNTARILY MADE BY EACH PARTY AND EACH PARTY EXPRESSLY ACKNOWLEDGES THAT NEITHER THE OTHER PARTY NOR ANY PERSON ACTING ON BEHALF OF THE OTHER PARTY HAS MADE ANY REPRESENTATIONS OF FACT TO INDUCE THIS WAIVER OF TRIAL BY JURY OR IN ANY WAY TO MODIFY OR NULLIFY ITS EFFECT. EACH PARTY ACKNOWLEDGES TO THE OTHER THAT IT HAS READ AND UNDERSTANDS THE MEANING AND EFFECT OF THIS WAIVER PROVISION.

2

      8.  Severability . If for any reason any provision of this Agreement is held invalid, such invalidity shall not affect any other provision of this Agreement not held invalid, and all such other provisions shall continue in full force and effect. If any provision of this Agreement shall be held invalid in part, such invalidities shall in no way affect the rest of such provision not held so invalid, and the rest of such provision, together with all other provisions of this Agreement, shall to the full extent consistent with law, continue in full force and effect.

      9.  Notices . Any notice or communication given pursuant hereto by any party shall be in writing and hand delivered or mailed by registered or certified mail, postage prepaid, to the party at the address set forth below or to such other address as a party may designate by written notice given to the other party in accordance with this provision.

      10.  Headings . The headings of the paragraphs of this Agreement are inserted for convenience of reference only and shall not constitute a part hereof.

      11.  Entire Agreement . This Agreement, including the other documents referred to herein which form a part hereof, contains the entire understanding of the parties hereto with respect to the subject matter contained herein and supersedes all prior agreements and understandings between the parties with respect to such subject matter.

      12.  Amendment . This Agreement may not be amended or modified except by instrument in writing signed by all of the parties.

      13.  Counterparts . This Agreement may be executed in any number of counterparts, by facsimile signature or otherwise, each of which shall be an original but all of which together shall constitute one and the same instrument.

[ Signature Page to Follow ]

3

      IN WITNESS WHEREOF , the parties hereto have executed this Agreement, effective the date first set forth above.

Acknowledged and Agreed

WOODCLIFF HEALTHCARE INVESTMENT PARTNERS, LLC

4

EXHIBIT 10.6

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT

      THIS AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (this “ Agreement ”) is made and entered into as of June 14, 2005, by and between COMPREHENSIVE CARE CORPORATION, a Delaware corporation (the “ Employer ”), and ROBERT J. LANDIS, an individual residing in the State of Florida (the “ Executive ”). Hereinafter, the Employer and the Executive are sometimes referred to individually as a “ Party ” and together as the “ Parties .”

W I T N E S S E T H:

      WHEREAS , the Parties have entered into an Employment Agreement, dated effective February 1, 2003, pursuant to which the Executive is employed as the Chairman, Chief Financial Officer and Treasurer of the Employer (the “ Employment Agreement ”); and

      WHEREAS , the Parties desire to hereby amend the Employment Agreement in the manner specified herein.

      NOW THEREFORE , in consideration of the mutual promises contained herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties hereto agree as follows:

      1.  Definitions . All capitalized terms appearing in this Agreement and defined in the Employment Agreement shall have the definitions ascribed thereto in the Employment Agreement, unless otherwise specifically provided for herein.

2. Amendment to Article XI . Article XI of the Employment Agreement is hereby amended by deleting said section in its entirety and replacing it with the following:

     This Agreement shall have an initial term commencing February 1, 2003 and terminating on May 31, 2006. This Agreement shall be automatically renewed and extended on its same terms and conditions for up to two consecutive eighteen month periods unless either party gives written notice to the other at least six months prior to the initial termination date or renewal termination date, as the case may be, of its intention not to renew. In the event that the Company notifies Executive of its intent not to renew this Agreement, the Company agrees to pay to Executive, upon the expiration of this Agreement without renewal, a lump sum severance payment equal to two (2) years Base Salary. In addition, and commencing upon the expiration of this Agreement without renewal, the Company shall, at its expense, continue to provide Executive with his existing healthcare insurance coverage for 18 months or such shorter period that the Company may legally continue Executive’s healthcare insurance, in which case the Company shall reimburse Executive for the cost of comparable healthcare insurance coverage for Executive and his dependents for the period commencing the time of termination or discontinuance of Executive’s existing healthcare insurance and 18 months following Executive’s separation from the Company. However, no such entitlement will continue once Executive has coverage through another employer or has been added onto coverage available through his spouse’s employer if applicable.

1

      3.  Amendment to Article XII . Article XII of the Employment Agreement is hereby amended by deleting said section in its entirety and replacing it with the following:

     In the event that the Executive becomes totally disabled so that he is unable or prevented from substantially performing his usual duties as set forth in Article III hereunder after sixty (60) days following a triggering event, he will be considered terminated without cause as defined under Article XIII (C). Full salary and benefits will continue during the sixty (60) day period. The obligation of the Company to make the aforesaid payments shall be modified and reduced and the Company shall receive a credit for all disability insurance payments which Executive may receive or to which he may become entitled; provided, however, that the premiums for such disability insurance had been paid by the Company or had been reimbursed to Executive by the Company.

      4.  Amendments to Article XIII(C) . In Article XIII, Section (C) of the Employment Agreement, in the last sentence, the words “curtailment or diminution of the Executive’s duties and responsibilities” are hereby deleted and replaced with “or total disability as defined in Article XII herein.”

      5.  Amendment to Article XIII(D). Article XIII is hereby amended by adding the following language as Section (D) of said article:

     (D) In the event the Company materially curtails or diminishes Executive’s duties and responsibilities, Executive may elect to voluntarily terminate his employment after providing at least sixty (60) days notice of his intent to do so, regardless of whether the term of this Agreement shall have expired. Materiality, for purposes of this paragraph, shall include, but not be limited to, inserting an employee between Executive and the Board of Directors, or between Executive and his direct reports, or excluding Executive from the strategic planning process. In the event Executive’s employment is terminated under the terms of this paragraph, he will receive a severance benefit equal to the greater of the Executive’s Base Salary for the unexpired term of the Agreement, or an amount equal to two times the amount of Executive’s Base Salary, whichever is greater.

      6.  Miscellaneous . Except as specifically set forth in this Agreement, all of the terms and provisions of the Employment Agreement shall continue to remain in full force and effect. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, and all of which together shall constitute one document. This Agreement, together with the Employment Agreement, contains the final, complete, and exclusive expression of the Parties’ understanding and agreement concerning the matters contemplated herein and supersedes any prior or contemporaneous agreement of representation, oral or written, among them.

2

      IN WITNESS WHEREOF , the parties have executed this Amendment No. 1 to Employment Agreement on the day and year first written above.

3